STOCK TITAN

Maximus (NYSE: MMS) grows earnings in Q2 2026 despite revenue dip

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
10-Q

Rhea-AI Filing Summary

Maximus, Inc. reported slightly lower revenue but stronger profitability for the quarter ended March 31, 2026. Quarterly revenue was $1.31 billion, down from $1.36 billion a year ago, while net income edged up to $98.1 million and diluted EPS rose to $1.80 from $1.69.

For the first six months, revenue declined 4.1% to $2.65 billion, but net income increased to $192.0 million from $137.8 million as gross margin improved to 24.9% and operating margin to 11.1%. Adjusted EBITDA for the six months reached $358.4 million, reflecting lower cost of revenue, divestiture gains, and a capitalized software impairment charge of $6.9 million.

The U.S. Federal Services segment expanded operating margin to 17.0% despite modest revenue declines, while U.S. Services and Outside the U.S. saw revenue and margin pressure, with the international segment posting an operating loss. Operating cash flow was negative $54.9 million, driven partly by delayed collections on a large U.S. federal contract, and days sales outstanding increased. Maximus repurchased about 1.8 million shares for $142.0 million, ended with a Consolidated Net Total Leverage Ratio of 1.75x, and the board declared a quarterly dividend of $0.33 per share.

Positive

  • Margin and earnings expansion: Six-month net income rose to $192.0 million from $137.8 million and operating margin improved to 11.1%, with Adjusted EBITDA reaching $358.4 million despite lower revenue.

Negative

  • None.

Insights

Profitability and EPS are improving despite modest revenue declines.

Maximus delivered mixed top-line but clearly stronger bottom-line results. Six-month revenue fell to $2.65 billion, yet net income increased to $192.0 million as gross margin rose and operating margin expanded to 11.1%. Adjusted EBITDA reached $358.4 million, showing solid underlying earnings power.

Segment trends are uneven. U.S. Federal Services grew margins to high teens as short-term disaster work rolled off and operations became more efficient. U.S. Services and Outside the U.S. saw lower volumes, with the international segment reporting an operating loss, which pulls on consolidated growth and diversification benefits.

From a balance sheet perspective, funded debt totals $1.55 billion and the Consolidated Net Total Leverage Ratio is a moderate 1.75x. However, operating cash flow was negative $54.9 million for the six months and DSO increased, reflecting delayed federal collections. Continued share repurchases and a $0.33 quarterly dividend return capital to shareholders, while ongoing MOVEit-related litigation and associated accruals remain an overhang to monitor through future filings.

Q2 2026 Revenue $1,305.97M Three months ended March 31, 2026
Q2 2026 Net Income $98.06M Three months ended March 31, 2026
Q2 2026 Diluted EPS $1.80 per share Three months ended March 31, 2026
Six-month Revenue $2,651.01M Six months ended March 31, 2026
Six-month Adjusted EBITDA $358.44M Non-GAAP, six months ended March 31, 2026
Operating Cash Flow -$54.88M Net cash used in operating activities, six months ended March 31, 2026
Total Debt Principal $1,546.88M As of March 31, 2026
Net Total Leverage Ratio 1.75x Consolidated Net Total Leverage Ratio per Credit Agreement, TTM March 31, 2026
Adjusted EBITDA financial
"Adjusted EBITDA (Non-GAAP) | $ | 188,027 | $ | 186,406 | $ | 358,441 | $ | 343,024"
Adjusted EBITDA is a way companies measure how much money they make from their core operations, like running a business, by removing certain costs or income that aren’t part of regular business activities. It helps investors see how well a company is doing without distractions from unusual expenses or gains, making it easier to compare companies or track performance over time.
Receivables Purchase Agreement financial
"We have a Receivables Purchase Agreement (RPA) with Wells Fargo Bank N.A., under which we may sell certain U.S.-originated accounts receivable"
A receivables purchase agreement is a contract where a company sells its outstanding invoices or amounts owed by customers to a buyer in exchange for immediate cash, usually at a discount. Investors care because it improves a company’s short‑term cash flow and can change reported assets, liabilities and risk exposure—like selling IOUs to get money now instead of waiting, which affects liquidity and the firm’s financial picture.
Consolidated Net Total Leverage Ratio financial
"Our Consolidated Net Total Leverage Ratio means, for any twelve-month period, the ratio of our Funded Debt"
cash flow hedges financial
"We utilize interest rate swaps that are designed to reduce our risk from changes in interest rates, which we have designated as cash flow hedges."
A cash flow hedge is an accounting label companies use when they enter financial contracts—like currency or interest-rate agreements—to protect expected future cash payments or receipts from unpredictable moves. For investors, it signals that the company is trying to smooth out future cash variability (think of locking in a price to avoid surprises), which can reduce reported profit swings but also means the company has exposure to derivative instruments and their associated risks.
MOVEit cybersecurity incident financial
"arising out of the MOVEit cybersecurity incident – Bishop v. Maximus Federal Services"
000103222009/302026Q2FALSEhttp://fasb.org/us-gaap/2025#OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParentP3YP1Yxbrli:sharesiso4217:USDiso4217:USDxbrli:sharesmms:segmentxbrli:pure00010322202025-10-012026-03-3100010322202026-05-0400010322202026-01-012026-03-3100010322202025-01-012025-03-3100010322202024-10-012025-03-3100010322202026-03-3100010322202025-09-3000010322202024-09-3000010322202025-03-310001032220us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2025-09-300001032220us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-09-300001032220us-gaap:RetainedEarningsMember2025-09-300001032220us-gaap:RetainedEarningsMember2025-10-012025-12-3100010322202025-10-012025-12-310001032220us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-10-012025-12-310001032220us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2025-10-012025-12-310001032220us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2025-12-310001032220us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-12-310001032220us-gaap:RetainedEarningsMember2025-12-3100010322202025-12-310001032220us-gaap:RetainedEarningsMember2026-01-012026-03-310001032220us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-01-012026-03-310001032220us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2026-01-012026-03-310001032220us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2026-03-310001032220us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-03-310001032220us-gaap:RetainedEarningsMember2026-03-310001032220us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2024-09-300001032220us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-09-300001032220us-gaap:RetainedEarningsMember2024-09-300001032220us-gaap:RetainedEarningsMember2024-10-012024-12-3100010322202024-10-012024-12-310001032220us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-10-012024-12-310001032220us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2024-10-012024-12-310001032220us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2024-12-310001032220us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310001032220us-gaap:RetainedEarningsMember2024-12-3100010322202024-12-310001032220us-gaap:RetainedEarningsMember2025-01-012025-03-310001032220us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-03-310001032220us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2025-01-012025-03-310001032220us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2025-03-310001032220us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-03-310001032220us-gaap:RetainedEarningsMember2025-03-310001032220us-gaap:TechnologyEquipmentMember2026-03-310001032220us-gaap:TechnologyEquipmentMember2026-01-012026-03-310001032220us-gaap:OperatingSegmentsMembermms:U.S.FederalServicesMember2026-01-012026-03-310001032220us-gaap:OperatingSegmentsMembermms:USServicesMember2026-01-012026-03-310001032220us-gaap:OperatingSegmentsMembermms:OutsideTheUnitedStatesMember2026-01-012026-03-310001032220us-gaap:MaterialReconcilingItemsMember2026-01-012026-03-310001032220us-gaap:OperatingSegmentsMembermms:U.S.FederalServicesMember2025-01-012025-03-310001032220us-gaap:OperatingSegmentsMembermms:USServicesMember2025-01-012025-03-310001032220us-gaap:OperatingSegmentsMembermms:OutsideTheUnitedStatesMember2025-01-012025-03-310001032220us-gaap:MaterialReconcilingItemsMember2025-01-012025-03-310001032220us-gaap:OperatingSegmentsMembermms:U.S.FederalServicesMember2025-10-012026-03-310001032220us-gaap:OperatingSegmentsMembermms:USServicesMember2025-10-012026-03-310001032220us-gaap:OperatingSegmentsMembermms:OutsideTheUnitedStatesMember2025-10-012026-03-310001032220us-gaap:MaterialReconcilingItemsMember2025-10-012026-03-310001032220us-gaap:OperatingSegmentsMembermms:U.S.FederalServicesMember2024-10-012025-03-310001032220us-gaap:OperatingSegmentsMembermms:USServicesMember2024-10-012025-03-310001032220us-gaap:OperatingSegmentsMembermms:OutsideTheUnitedStatesMember2024-10-012025-03-310001032220us-gaap:MaterialReconcilingItemsMember2024-10-012025-03-310001032220mms:ProgramOperationsMember2026-01-012026-03-310001032220mms:ProgramOperationsMembermms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMember2026-01-012026-03-310001032220mms:ProgramOperationsMember2025-01-012025-03-310001032220mms:ProgramOperationsMembermms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-01-012025-03-310001032220mms:ProgramOperationsMember2025-10-012026-03-310001032220mms:ProgramOperationsMembermms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-10-012026-03-310001032220mms:ProgramOperationsMember2024-10-012025-03-310001032220mms:ProgramOperationsMembermms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-10-012025-03-310001032220mms:ClinicalServicesMember2026-01-012026-03-310001032220mms:ClinicalServicesMembermms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMember2026-01-012026-03-310001032220mms:ClinicalServicesMember2025-01-012025-03-310001032220mms:ClinicalServicesMembermms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-01-012025-03-310001032220mms:ClinicalServicesMember2025-10-012026-03-310001032220mms:ClinicalServicesMembermms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-10-012026-03-310001032220mms:ClinicalServicesMember2024-10-012025-03-310001032220mms:ClinicalServicesMembermms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-10-012025-03-310001032220mms:EmploymentAndOtherMember2026-01-012026-03-310001032220mms:EmploymentAndOtherMembermms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMember2026-01-012026-03-310001032220mms:EmploymentAndOtherMember2025-01-012025-03-310001032220mms:EmploymentAndOtherMembermms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-01-012025-03-310001032220mms:EmploymentAndOtherMember2025-10-012026-03-310001032220mms:EmploymentAndOtherMembermms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-10-012026-03-310001032220mms:EmploymentAndOtherMember2024-10-012025-03-310001032220mms:EmploymentAndOtherMembermms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-10-012025-03-310001032220mms:TechnologySolutionsMember2026-01-012026-03-310001032220mms:TechnologySolutionsMembermms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMember2026-01-012026-03-310001032220mms:TechnologySolutionsMember2025-01-012025-03-310001032220mms:TechnologySolutionsMembermms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-01-012025-03-310001032220mms:TechnologySolutionsMember2025-10-012026-03-310001032220mms:TechnologySolutionsMembermms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-10-012026-03-310001032220mms:TechnologySolutionsMember2024-10-012025-03-310001032220mms:TechnologySolutionsMembermms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-10-012025-03-310001032220mms:PerformanceBasedContractsMember2026-01-012026-03-310001032220mms:PerformanceBasedContractsMembermms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMember2026-01-012026-03-310001032220mms:PerformanceBasedContractsMember2025-01-012025-03-310001032220mms:PerformanceBasedContractsMembermms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-01-012025-03-310001032220mms:PerformanceBasedContractsMember2025-10-012026-03-310001032220mms:PerformanceBasedContractsMembermms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-10-012026-03-310001032220mms:PerformanceBasedContractsMember2024-10-012025-03-310001032220mms:PerformanceBasedContractsMembermms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-10-012025-03-310001032220mms:CostPlusContractsMember2026-01-012026-03-310001032220mms:CostPlusContractsMembermms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMember2026-01-012026-03-310001032220mms:CostPlusContractsMember2025-01-012025-03-310001032220mms:CostPlusContractsMembermms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-01-012025-03-310001032220mms:CostPlusContractsMember2025-10-012026-03-310001032220mms:CostPlusContractsMembermms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-10-012026-03-310001032220mms:CostPlusContractsMember2024-10-012025-03-310001032220mms:CostPlusContractsMembermms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-10-012025-03-310001032220us-gaap:FixedPriceContractMember2026-01-012026-03-310001032220us-gaap:FixedPriceContractMembermms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMember2026-01-012026-03-310001032220us-gaap:FixedPriceContractMember2025-01-012025-03-310001032220us-gaap:FixedPriceContractMembermms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-01-012025-03-310001032220us-gaap:FixedPriceContractMember2025-10-012026-03-310001032220us-gaap:FixedPriceContractMembermms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-10-012026-03-310001032220us-gaap:FixedPriceContractMember2024-10-012025-03-310001032220us-gaap:FixedPriceContractMembermms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-10-012025-03-310001032220us-gaap:TimeAndMaterialsContractMember2026-01-012026-03-310001032220us-gaap:TimeAndMaterialsContractMembermms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMember2026-01-012026-03-310001032220us-gaap:TimeAndMaterialsContractMember2025-01-012025-03-310001032220us-gaap:TimeAndMaterialsContractMembermms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-01-012025-03-310001032220us-gaap:TimeAndMaterialsContractMember2025-10-012026-03-310001032220us-gaap:TimeAndMaterialsContractMembermms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-10-012026-03-310001032220us-gaap:TimeAndMaterialsContractMember2024-10-012025-03-310001032220us-gaap:TimeAndMaterialsContractMembermms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-10-012025-03-310001032220mms:NewYorkStateGovernmentAgenciesMember2026-01-012026-03-310001032220mms:NewYorkStateGovernmentAgenciesMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2026-01-012026-03-310001032220mms:NewYorkStateGovernmentAgenciesMember2025-01-012025-03-310001032220mms:NewYorkStateGovernmentAgenciesMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-01-012025-03-310001032220mms:NewYorkStateGovernmentAgenciesMember2025-10-012026-03-310001032220mms:NewYorkStateGovernmentAgenciesMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-10-012026-03-310001032220mms:NewYorkStateGovernmentAgenciesMember2024-10-012025-03-310001032220mms:NewYorkStateGovernmentAgenciesMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-10-012025-03-310001032220mms:OtherUnitedStateGovernmentAgenciesMember2026-01-012026-03-310001032220mms:OtherUnitedStateGovernmentAgenciesMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2026-01-012026-03-310001032220mms:OtherUnitedStateGovernmentAgenciesMember2025-01-012025-03-310001032220mms:OtherUnitedStateGovernmentAgenciesMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-01-012025-03-310001032220mms:OtherUnitedStateGovernmentAgenciesMember2025-10-012026-03-310001032220mms:OtherUnitedStateGovernmentAgenciesMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-10-012026-03-310001032220mms:OtherUnitedStateGovernmentAgenciesMember2024-10-012025-03-310001032220mms:OtherUnitedStateGovernmentAgenciesMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-10-012025-03-310001032220mms:TotalUnitedStatesStateGovernmentAgenciesMember2026-01-012026-03-310001032220mms:TotalUnitedStatesStateGovernmentAgenciesMember2025-01-012025-03-310001032220mms:TotalUnitedStatesStateGovernmentAgenciesMember2025-10-012026-03-310001032220mms:TotalUnitedStatesStateGovernmentAgenciesMember2024-10-012025-03-310001032220mms:UnitedStatesFederalGovernmentAgenciesMember2026-01-012026-03-310001032220mms:UnitedStatesFederalGovernmentAgenciesMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2026-01-012026-03-310001032220mms:UnitedStatesFederalGovernmentAgenciesMember2025-01-012025-03-310001032220mms:UnitedStatesFederalGovernmentAgenciesMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-01-012025-03-310001032220mms:UnitedStatesFederalGovernmentAgenciesMember2025-10-012026-03-310001032220mms:UnitedStatesFederalGovernmentAgenciesMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-10-012026-03-310001032220mms:UnitedStatesFederalGovernmentAgenciesMember2024-10-012025-03-310001032220mms:UnitedStatesFederalGovernmentAgenciesMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-10-012025-03-310001032220mms:InternationalGovernmentAgenciesMember2026-01-012026-03-310001032220mms:InternationalGovernmentAgenciesMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2026-01-012026-03-310001032220mms:InternationalGovernmentAgenciesMember2025-01-012025-03-310001032220mms:InternationalGovernmentAgenciesMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-01-012025-03-310001032220mms:InternationalGovernmentAgenciesMember2025-10-012026-03-310001032220mms:InternationalGovernmentAgenciesMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-10-012026-03-310001032220mms:InternationalGovernmentAgenciesMember2024-10-012025-03-310001032220mms:InternationalGovernmentAgenciesMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-10-012025-03-310001032220mms:OtherIncludingLocalMunicipalitiesAndCommercialCustomersMember2026-01-012026-03-310001032220mms:OtherIncludingLocalMunicipalitiesAndCommercialCustomersMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2026-01-012026-03-310001032220mms:OtherIncludingLocalMunicipalitiesAndCommercialCustomersMember2025-01-012025-03-310001032220mms:OtherIncludingLocalMunicipalitiesAndCommercialCustomersMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-01-012025-03-310001032220mms:OtherIncludingLocalMunicipalitiesAndCommercialCustomersMember2025-10-012026-03-310001032220mms:OtherIncludingLocalMunicipalitiesAndCommercialCustomersMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-10-012026-03-310001032220mms:OtherIncludingLocalMunicipalitiesAndCommercialCustomersMember2024-10-012025-03-310001032220mms:OtherIncludingLocalMunicipalitiesAndCommercialCustomersMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-10-012025-03-310001032220us-gaap:UnbilledRevenuesMember2026-03-310001032220us-gaap:UnbilledRevenuesMember2025-09-300001032220us-gaap:ChangeInAccountingMethodAccountedForAsChangeInEstimateMember2026-01-012026-03-310001032220us-gaap:ChangeInAccountingMethodAccountedForAsChangeInEstimateMember2025-01-012025-03-310001032220us-gaap:ChangeInAccountingMethodAccountedForAsChangeInEstimateMember2025-10-012026-03-310001032220us-gaap:ChangeInAccountingMethodAccountedForAsChangeInEstimateMember2024-10-012025-03-3100010322202026-04-012026-03-310001032220us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMembermms:ChildSupportBusinessInTheUnitedStatesMember2025-12-310001032220us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMembermms:ChildSupportBusinessInTheUnitedStatesMember2025-12-012025-12-310001032220us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMembermms:BusinessesInAustraliaAndKoreaMember2024-12-012024-12-310001032220mms:TermLoanADue2029Memberus-gaap:SecuredDebtMember2026-03-310001032220mms:TermLoanADue2029Memberus-gaap:SecuredDebtMember2025-09-300001032220mms:TermLoanBDue2031Memberus-gaap:SecuredDebtMember2026-03-310001032220mms:TermLoanBDue2031Memberus-gaap:SecuredDebtMember2025-09-300001032220us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2026-03-310001032220us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2025-09-300001032220us-gaap:InterestRateSwapMembermms:TermLoanADueMay2026Memberus-gaap:SecuredDebtMember2026-03-310001032220us-gaap:InterestRateSwapMembermms:TermLoanBDueSeptember2026Memberus-gaap:SecuredDebtMember2026-03-310001032220us-gaap:InterestRateSwapMembermms:TermLoanBDueSeptember2027Memberus-gaap:SecuredDebtMember2026-03-310001032220us-gaap:InterestRateSwapMembermms:TermLoanADueSeptember2027Memberus-gaap:SecuredDebtMember2026-03-310001032220us-gaap:InterestRateSwapMembermms:TermLoanADueSeptember2028Memberus-gaap:SecuredDebtMember2026-03-310001032220us-gaap:OtherAssetsMember2026-03-310001032220us-gaap:OtherLiabilitiesMember2026-03-310001032220us-gaap:OtherAssetsMember2025-09-300001032220us-gaap:OtherLiabilitiesMember2025-09-300001032220us-gaap:MutualFundMemberus-gaap:FairValueInputsLevel1Member2026-03-310001032220us-gaap:MutualFundMemberus-gaap:FairValueInputsLevel2Member2026-03-310001032220us-gaap:MutualFundMemberus-gaap:FairValueInputsLevel3Member2026-03-310001032220us-gaap:MutualFundMember2026-03-310001032220us-gaap:InterestRateSwapMember2026-03-310001032220us-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel1Member2026-03-310001032220us-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel2Member2026-03-310001032220us-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel3Member2026-03-310001032220us-gaap:FairValueInputsLevel1Member2026-03-310001032220us-gaap:FairValueInputsLevel2Member2026-03-310001032220us-gaap:FairValueInputsLevel3Member2026-03-310001032220us-gaap:AccumulatedTranslationAdjustmentMember2025-09-300001032220us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2025-09-300001032220us-gaap:AccumulatedTranslationAdjustmentMember2025-10-012026-03-310001032220us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2025-10-012026-03-310001032220us-gaap:AccumulatedTranslationAdjustmentMember2026-03-310001032220us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2026-03-310001032220us-gaap:RestrictedStockUnitsRSUMembersrt:MinimumMembermms:EmployeeMember2025-10-012026-03-310001032220us-gaap:RestrictedStockUnitsRSUMembersrt:MaximumMembermms:EmployeeMember2025-10-012026-03-310001032220mms:EmployeeMemberus-gaap:RestrictedStockUnitsRSUMember2025-10-012026-03-310001032220srt:DirectorMemberus-gaap:RestrictedStockUnitsRSUMember2025-10-012026-03-310001032220srt:MinimumMemberus-gaap:PerformanceSharesMember2025-10-012026-03-310001032220srt:MaximumMemberus-gaap:PerformanceSharesMember2025-10-012026-03-310001032220us-gaap:PerformanceSharesMember2025-10-012026-03-310001032220us-gaap:RestrictedStockUnitsRSUMember2025-10-012026-03-310001032220srt:MinimumMemberus-gaap:RestrictedStockUnitsRSUMember2025-10-012026-03-310001032220srt:MaximumMemberus-gaap:RestrictedStockUnitsRSUMember2025-10-012026-03-310001032220us-gaap:SubsequentEventMember2026-04-012026-05-070001032220us-gaap:SubsequentEventMember2026-05-070001032220us-gaap:BilledRevenuesMember2026-03-310001032220us-gaap:BilledRevenuesMember2025-09-300001032220us-gaap:SubsequentEventMember2026-04-062026-04-06
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q
(Mark one)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2026
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from __________to__________.
Commission file number: 1-12997
Maximus_logo_2022.jpg

Maximus, Inc.
(Exact name of registrant as specified in its charter)
Virginia54-1000588
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)
1600 Tysons Boulevard, McLean, Virginia
22102
(Address of principal executive offices)
(Zip Code)
(703) 251-8500
(Registrant's telephone number, including the area code)

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, no par valueMMSNew York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).        Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer
 
Accelerated filer ☐
 
Non-accelerated filer ☐
Smaller reporting company 
Emerging growth company  
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No
There were 52,540,363 shares of the registrant's Common Stock outstanding as of May 4, 2026.


Table of Contents
Table of Contents to Second Quarter 2026 Form 10-Q
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
3
Part I - Financial Information
5
Item 1.
Financial Statements
5
Consolidated Statements of Operations
5
Consolidated Statements of Comprehensive Income
6
Consolidated Balance Sheets
7
Consolidated Statements of Cash Flows
8
Consolidated Statements of Changes in Shareholders’ Equity
9
Notes to Consolidated Financial Statements
11
1. Organization
11
2. Significant Accounting Policies
11
3. Business Segments
12
4. Revenue Recognition
15
5. Earnings Per Share
17
6. Divestitures
17
7. Debt and Derivatives
18
8. Fair Value Measurements
19
9. Equity
20
10. Other Items
21
11. Commitments and Contingencies
22
12. Subsequent Event
23
Item 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
24
Business Overview
24
Financial Overview
25
Results of Operations
25
Liquidity and Capital Resources
30
Critical Accounting Policies and Estimates
33
Non-GAAP and Other Measures
33
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
36
Item 4.
Controls and Procedures
36
Part II - Other Information
37
Item 1.
Legal Proceedings
37
Item 1A.
Risk Factors
37
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
37
Item 3.
Defaults Upon Senior Securities
37
Item 4.
Mine Safety Disclosures
37
Item 5.
Other Information
37
Item 6.
Exhibits
38
Signatures
39

2

Table of Contents
Unless otherwise specified, references in this Quarterly Report on Form 10-Q to "our," "we," "us," "Maximus," the "Company," and "our business" refer to Maximus, Inc. and its subsidiaries.
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
Included in this Quarterly Report on Form 10-Q are forward-looking statements within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: "anticipate," "intend," "plan," "goal," "seek," “on track,” "opportunity," "could," "potential," "believe," "project," "estimate," "expect," "continue," "forecast," "strategy," "future," "likely," "may," "should," "will," and similar references to future periods.
Any statements herein that are not historical facts, including statements about our confidence, strategies and initiatives, and our expectations about revenues, results of operations, profitability, future contracts, liquidity, market opportunities, market demand, acceptance of our products and service offerings, or acquisitions and divestitures, are forward-looking statements that are subject to risks and uncertainties. These risks could cause our actual results to differ materially from those indicated by such forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following:
a failure to meet performance requirements under our contracts could lead to penalties, liquidated damages, actual damages, adverse settlement agreements, and/or contract termination;
our ability to successfully compete, bid for, and accurately price contracts to generate our desired profit;
the effects of future legislative or government budgetary and spending changes, including the impact of a prolonged U.S. government shutdown;
the impact of the U.S. government on federal procurement, federal funding to states' safety-net programs, and the overall decision-making process related to our industry, including our business and customers;
the ability of the U.S. government to issue or revise existing rules, regulations, executive orders, and directives at any time, or to take non-routine actions, which creates uncertainty for our business operations and requires significant additional compliance efforts and costs;
our ability to manage our growth, including acquired businesses;
difficulties in integrating or achieving projected revenues, earnings, and other benefits associated with acquired businesses;
the outcome of reviews or audits, which might result in financial penalties and impair our ability to respond to invitations for new work;
our ability to manage capital investments and other contract startup costs;
our ability to manage our debt;
our ability to maintain our technology systems and otherwise protect confidential or protected information;
our discovery of additional information related to our previously disclosed cybersecurity incident and any potential legal, business, reputational, or financial consequences resulting from that incident or any cybersecurity incidents;
our ability to attract and retain executive officers, senior managers, and other qualified personnel to execute our business;
the effect of union activity and organizing efforts at our U.S. locations;
the ability of government customers to not exercise options, or to recompete or terminate contracts on short notice, with or without cause;
our ability to win recompetes and/or succeed in protests on our significant contracts;
our reliance on a small number of individual contracts and customers;
our ability to realize the full value of our backlog;
our ability to maintain relationships with key government entities from whom a substantial portion of our revenue is derived;
a failure to comply with laws governing our business, which might result in the Company being subject to fines, penalties, suspension, debarment, and other sanctions;
the costs and outcome of litigation;
our ability to manage third parties upon whom we depend to provide services to our customers;
the effects of changes in laws and regulations governing our business, including actions resulting from non-routine government actions or orders, changes in tax laws and applicable interpretations and guidance thereunder, or changes in accounting policies, rules, methodologies, and practices, and our ability to estimate the impact of such changes including shifting macroeconomic conditions and uncertainty;
3

Table of Contents
the effects of emerging technologies, such as artificial intelligence (AI) and machine learning (ML), on our business;
matters related to businesses we disposed of or divested; and
other factors set forth in Item 1A, "Risk Factors" of our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (SEC) on November 20, 2025.
Any forward-looking statement made by us in this report is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments, or otherwise.
4

Table of Contents
PART I - Financial Information
Item 1. Financial Statements
Maximus, Inc.
Consolidated Statements of Operations
(Unaudited)
For the Three Months EndedFor the Six Months Ended
March 31, 2026March 31, 2025March 31, 2026March 31, 2025
(in thousands, except per share amounts)
Revenue$1,305,967 $1,361,786 $2,651,013 $2,764,461 
Cost of revenue963,703 1,022,965 1,990,079 2,124,083 
Gross profit342,264 338,821 660,934 640,378 
Selling, general, and administrative expenses173,479 162,857 325,639 354,592 
Amortization of intangible assets20,298 22,996 40,598 46,031 
Operating income148,487 152,968 294,697 239,755 
Interest expense22,111 21,469 42,927 38,991 
Other (income)/expense, net(158)(963)(1,031)(651)
Income before income taxes126,534 132,462 252,801 201,415 
Provision for income taxes28,471 35,893 60,795 63,650 
Net income$98,063 $96,569 $192,006 $137,765 
Earnings per share:
Basic$1.81 $1.70 $3.52 $2.36 
Diluted$1.80 $1.69 $3.50 $2.35 
Weighted average shares outstanding:
Basic54,242 56,892 54,547 58,330 
Diluted54,585 57,057 54,925 58,553 
Dividends declared per share$0.33 $0.30 $0.63 $0.60 
See accompanying notes to consolidated financial statements.
5

Table of Contents
Maximus, Inc.
Consolidated Statements of Comprehensive Income
(Unaudited)
For the Three Months EndedFor the Six Months Ended
March 31, 2026March 31, 2025March 31, 2026March 31, 2025
(in thousands)
Net income$98,063 $96,569 $192,006 $137,765 
Other comprehensive (loss)/income, net of tax:
Foreign currency translation adjustments(2,779)3,731 (2,531)14,183 
Net gains/(losses) on cash flow hedges, net of tax provision/(benefit) of $268, $(911), $(234), and $(35), respectively
750 (2,552)(657)(98)
Other comprehensive (loss)/income(2,029)1,179 (3,188)14,085 
Comprehensive income$96,034 $97,748 $188,818 $151,850 
See accompanying notes to consolidated financial statements.
6

Table of Contents
Maximus, Inc.
Consolidated Balance Sheets
March 31, 2026September 30, 2025
(unaudited)
(in thousands)
Assets:
Cash and cash equivalents$157,452 $222,351 
Accounts receivable, net1,114,960 898,095 
Income taxes receivable64,792 3,904 
Prepaid expenses and other current assets171,644 128,574 
Total current assets1,508,848 1,252,924 
Property and equipment, net27,178 30,972 
Capitalized software, net202,583 214,260 
Operating lease right-of-use assets84,097 100,514 
Goodwill1,780,507 1,782,095 
Intangible assets, net497,342 538,266 
Deferred contract costs, net62,737 63,332 
Deferred compensation plan assets58,472 63,272 
Deferred income taxes7,590 11,491 
Other assets9,820 12,513 
Total assets$4,239,174 $4,069,639 
Liabilities and Shareholders' Equity:
Liabilities:
Accounts payable and accrued liabilities$281,984 $296,888 
Accrued compensation and benefits152,362 236,948 
Deferred revenue, current portion37,910 53,784 
Income taxes payable959 17,321 
Long-term debt, current portion63,930 52,680 
Operating lease liabilities, current portion35,400 38,605 
Other current liabilities109,142 68,937 
Total current liabilities681,687 765,163 
Deferred revenue, non-current portion37,662 43,757 
Deferred income taxes212,703 149,020 
Long-term debt, non-current portion1,471,816 1,281,593 
Deferred compensation plan liabilities, non-current portion58,171 62,145 
Operating lease liabilities, non-current portion56,640 71,289 
Other liabilities23,534 22,637 
Total liabilities2,542,213 2,395,604 
Commitments and contingencies (Note 11)
Shareholders' equity:
Common stock, no par value; 100,000 shares authorized; 53,110 and 54,805 shares issued and outstanding as of March 31, 2026 and September 30, 2025, respectively
639,269 628,118 
Accumulated other comprehensive loss(21,055)(17,867)
Retained earnings1,078,747 1,063,784 
Total shareholders' equity1,696,961 1,674,035 
Total liabilities and shareholders' equity$4,239,174 $4,069,639 
See accompanying notes to consolidated financial statements.
7

Table of Contents
Maximus, Inc.
Consolidated Statements of Cash Flows
(Unaudited)
For the Six Months Ended
March 31, 2026March 31, 2025
(in thousands)
Cash flows from operating activities:
Net income$192,006 $137,765 
Adjustments to reconcile net income to cash flows from operations:
Depreciation and amortization of property, equipment, and capitalized software25,217 17,895 
Capitalized software impairment charges6,914  
Amortization of intangible assets40,598 46,031 
Amortization of debt issuance costs and debt discount1,472 1,310 
Deferred income taxes67,781 (590)
Stock compensation expense16,918 19,575 
Divestiture-related charges/(gains)(8,985)39,343 
Change in assets and liabilities, net of effects of business combinations and divestitures:
Accounts receivable(222,665)(234,882)
Prepaid expenses and other current assets5,963 7,943 
Deferred contract costs438 (1,915)
Accounts payable and accrued liabilities(14,238)5,943 
Accrued compensation and benefits(73,431)(48,001)
Deferred revenue(21,602)(11,293)
Income taxes(74,463)(6,465)
Operating lease right-of-use assets and liabilities(1,473)(2,363)
Other assets and liabilities4,674 (7,578)
Net cash used in operating activities(54,876)(37,282)
Cash flows from investing activities:
Purchases of property and equipment and capitalized software(16,772)(40,198)
Proceeds from divestitures12,895 736 
Other (2,165)
Net cash used in investing activities(3,877)(41,627)
Cash flows from financing activities:
Cash dividends paid to Maximus shareholders(34,159)(34,961)
Purchases of Maximus common stock(155,002)(306,443)
Tax withholding related to RSU vesting(17,325)(16,441)
Payments for debt financing costs (1,658)
Proceeds from borrowings665,000 959,000 
Principal payments for debt(465,000)(597,639)
Other, including customer escrowed funds50,109 (1,181)
Net cash provided by financing activities43,623 677 
Effect of exchange rate changes on cash, cash equivalents, and restricted cash(632)(1,593)
Net change in cash, cash equivalents, and restricted cash(15,762)(79,825)
Cash, cash equivalents, and restricted cash, beginning of period260,459 235,763 
Cash, cash equivalents, and restricted cash, end of period$244,697 $155,938 
See accompanying notes to consolidated financial statements.
8

Table of Contents
Maximus, Inc.
Consolidated Statements of Changes in Shareholders' Equity
(Unaudited)
Common StockAccumulated
Other
Comprehensive
Loss
Retained
Earnings
Total
Shareholders' Equity
SharesAmount
(in thousands)
Balance as of September 30, 202554,805$628,118 $(17,867)$1,063,784 $1,674,035 
Net income— — 93,943 93,943 
Foreign currency translation— 248 — 248 
Cash flow hedge, net of tax— (1,407)— (1,407)
Cash dividends— — (16,338)(16,338)
Dividends on RSUs363 — (363) 
Purchases of Maximus common stock(353)— — (31,055)(31,055)
Stock compensation expense7,019 — — 7,019 
Tax withholding adjustment related to RSU vesting(6,633)— — (6,633)
RSUs vested97— — — — 
Balance as of December 31, 202554,549628,867 (19,026)1,109,971 1,719,812 
Net income— — 98,063 98,063 
Foreign currency translation— (2,779)— (2,779)
Cash flow hedge, net of tax— 750 — 750 
Cash dividends— — (17,821)(17,821)
Dividends on RSUs503 — (503) 
Purchases of Maximus common stock(1,445)— — (110,963)(110,963)
Stock compensation expense9,899 — — 9,899 
RSUs vested6— — — — 
Balance as of March 31, 202653,110$639,269 $(21,055)$1,078,747 $1,696,961 
9

Table of Contents
Common StockAccumulated
Other
Comprehensive
Loss
Retained
Earnings
Total
Shareholders' Equity
SharesAmount
(in thousands)
Balance at September 30, 202460,352$598,304 $(32,460)$1,276,971 $1,842,815 
Net income— — 41,196 41,196 
Foreign currency translation— 10,452 — 10,452 
Cash flow hedge, net of tax— 2,454 — 2,454 
Cash dividends— — (18,060)(18,060)
Dividends on RSUs301 — (301) 
Purchases of Maximus common stock(3,113)— — (236,655)(236,655)
Stock compensation expense6,952 — — 6,952 
Tax withholding adjustment related to RSU vesting(2,305)— — (2,305)
RSUs vested47— — — — 
Balance as of December 31, 202457,286603,252 (19,554)1,063,151 1,646,849 
Net income— — 96,569 96,569 
Foreign currency translation— 3,731 — 3,731 
Cash flow hedge, net of tax— (2,552)— (2,552)
Cash dividends— — (16,901)(16,901)
Dividends on RSUs440 — (440) 
Purchases of Maximus common stock(947)— — (72,845)(72,845)
Stock compensation expense12,623 — — 12,623 
RSUs vested10— — — — 
Balance as of March 31, 202556,349$616,315 $(18,375)$1,069,534 $1,667,474 
See accompanying notes to consolidated financial statements.

10

Table of Contents
Maximus, Inc.
Notes to the Consolidated Financial Statements
1. ORGANIZATION
Maximus, a Virginia corporation, is a leading provider of tech-enabled services to government agencies. By moving people, technology, and government forward, Maximus helps improve the delivery of public services for more than 100 million American citizens amid complex technological, health, economic, and social challenges. As a trusted and accountable partner to primarily U.S. federal and state customers, we proudly design, develop, and deliver innovative and efficient programs that are designed to improve government’s effectiveness in serving its citizens.

2. SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The accompanying consolidated financial statements, including the notes, include our accounts and those of our wholly-owned subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States, or U.S. GAAP, and the rules and regulations of the Securities and Exchange Commission (SEC). All intercompany balances and transactions have been eliminated in consolidation.
Basis of Presentation for Interim Periods
Certain information and disclosures normally included for the annual financial statements to be prepared in accordance with U.S. GAAP have been condensed or omitted for the interim periods presented. We believe that the unaudited interim financial statements include all adjustments (which are normal and recurring in nature) necessary to present fairly our financial position and the results of operations and cash flows for the periods presented.
The results of operations for the interim periods presented are not necessarily indicative of results that may be expected for the year or future periods. The financial statements should be read in conjunction with our audited consolidated financial statements and the accompanying notes contained in our Annual Report on Form 10-K for the fiscal year ended September 30, 2025. We have continued to follow the accounting policies set forth in those financial statements.
Use of Estimates
The preparation of these financial statements, in conformity with U.S. GAAP, requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities, and the reported amounts of revenue and expenses. At each reporting period end, we make estimates, including those related to revenue recognition and cost estimation on certain contracts, the realizability of long-lived assets, and amounts related to income taxes, certain accrued liabilities, and contingencies and litigation.
At March 31, 2026, our capitalized software balance includes $32.9 million related to technology for new services within our U.S. Services Segment. During the second quarter of fiscal year 2026, we recorded an impairment charge of $6.9 million to an asset following a client decision which resulted in its carrying value no longer being recoverable. At this time, we believe that the remaining balance of these assets is recoverable. We continue to monitor these assets, and if circumstances change, we may be required to further adjust the value or useful life of the remaining assets.
11

Table of Contents
3. BUSINESS SEGMENTS
We conduct our operations through three business segments: U.S. Federal Services, U.S. Services, and Outside the U.S. Our operating segments represent the manner in which our Chief Executive Officer (CEO), who is our Chief Operating Decision Maker (CODM), reviews our financial results. The CODM reviews segment-level revenue, gross profit, and segment operating income/(loss) on a regular basis to assess performance and manage the business. Revenue is used to evaluate growth trends and performance relative to budget, while gross profit and segment operating income/(loss) are used to assess overall profitability, business efficiency, and the effectiveness of cost-reduction initiatives. These measures also inform the CODM’s decisions regarding the allocation of resources across segments, including allocations of management bonus as well as investments in technology, personnel, and strategic transactions, such as mergers and acquisitions.
U.S. Federal Services
Our U.S. Federal Services Segment delivers solutions that help various U.S. federal government agencies better execute on their mission, including program operations and management, clinical services, and advanced technology solutions.
U.S. Services
Our U.S. Services Segment provides a variety of services, such as program operations, clinical services, employment services and advanced technology solutions and related professional services work for U.S. state and local government programs. These services support a variety of programs, including the programs under Medicaid and Children's Health Insurance Program (CHIP), the Affordable Care Act (ACA) marketplaces, and Temporary Assistance to Needy Families (TANF).
Outside the U.S.
Our Outside the U.S. Segment provides business process services and other solutions for international governments. These services include health and disability assessments, program administration for employment services, wellbeing solutions and other job seeker-related services, digitally-enabled customer services, and advanced technologies for modernization. We support programs and deliver services in the United Kingdom, including the Functional Assessment Services (FAS) contract and the Restart employment program. We also provide services in Canada and the Middle East.

















12

Table of Contents
Table 3.1: Results of Operations by Business Segment for the Three Months Ended
 For the Three Months Ended March 31, 2026
(dollars in thousands)U.S. Federal Services% (1 )U.S. Services% (1 )Outside the U.S.% (1 )Total
Revenue$753,143 $415,754 $137,070 $1,305,967 
Cost of revenue527,698 70.1 %315,245 75.8 %120,760 88.1 %963,703 
Gross profit225,445 29.9 %100,509 24.2 %16,310 11.9 %342,264 
Other segment items (2)92,741 12.3 %61,919 14.9 %19,395 14.1 %174,055 
Segment operating income/(loss)$132,704 17.6 %$38,590 9.3 %$(3,085)(2.3)%168,209 
Other (4)576 
Amortization of intangible assets(20,298)
Operating income$148,487 
Depreciation and amortization:$7,300 1.0 %$4,161 1.0 %$867 0.6 %$12,328 
For the Three Months Ended March 31, 2025
(dollars in thousands)U.S. Federal Services% (1)U.S. Services% (1)Outside the U.S.% (1)Total
Revenue$777,927 $442,350 $141,509 $1,361,786 
Cost of revenue575,869 74.0 %330,580 74.7 %116,516 82.3 %1,022,965 
Gross profit202,058 26.0 %111,770 25.3 %24,993 17.7 %338,821 
Other segment items (2)83,076 10.7 %57,963 13.1 %20,197 14.3 %161,236 
Segment operating income$118,982 15.3 %$53,807 12.2 %$4,796 3.4 %177,585 
Divestiture-related gains/(charges) (3)(1,002)
Other (4)(619)
Amortization of intangible assets(22,996)
Operating income$152,968 
Depreciation and amortization:$3,677 0.5 %$4,161 0.9 %$1,602 1.1 %$9,440 

13

Table of Contents
Table 3.2: Results of Operations by Business Segment for the Six Months Ended
For the Six Months Ended March 31, 2026
(dollars in thousands)U.S. Federal Services% (1)U.S. Services% (1)Outside the U.S.% (1)Total
Revenue$1,539,744 $831,002 $280,267 $2,651,013 
Cost of revenue1,099,364 71.4 %646,099 77.7 %244,616 87.3 %1,990,079 
Gross profit440,380 28.6 %184,903 22.3 %35,651 12.7 %660,934 
Other segment items (2)177,943 11.6 %117,027 14.1 %40,116 14.3 %335,086 
Segment operating income$262,437 17.0 %$67,876 8.2 %$(4,465)(1.6)%325,848 
Divestiture-related gains/(charges) (3)8,985 
Other (4)462 
Amortization of intangible assets(40,598)
Operating income$294,697 
Depreciation and amortization:$14,415 0.9 %$8,383 1.0 %$2,419 0.9 %$25,217 
For the Six Months Ended March 31, 2025
(dollars in thousands)U.S. Federal Services% (1)U.S. Services% (1)Outside the U.S.% (1)Total
Revenue$1,558,582 $894,600 $311,279 $2,764,461 
Cost of revenue1,183,209 75.9 %687,826 76.9 %253,048 81.3 %2,124,083 
Gross profit375,373 24.1 %206,774 23.1 %58,231 18.7 %640,378 
Other segment items (2)157,291 10.1 %112,121 12.5 %45,315 14.6 %314,727 
Segment operating income$218,082 14.0 %$94,653 10.6 %$12,916 4.1 %325,651 
Divestiture-related gains/(charges) (3)(39,343)
Other (4)(522)
Amortization of intangible assets(46,031)
Operating income$239,755 
Depreciation and amortization:$6,528 0.4 %$7,972 0.9 %$3,395 1.1 %$17,895 
(1)Percentage of respective revenue, as applicable.
(2)Other segment items are principally selling, general, and administrative expenses allocated to segments.
(3)During fiscal years 2026 and 2025, we divested businesses from our U.S. Services and Outside the U.S. Segments, respectively. See "Note 6. Divestitures" for additional information.
(4)Other expenses include credits and costs that are not allocated to a particular segment.




14

Table of Contents
4. REVENUE RECOGNITION
We recognize revenue as, or when, we satisfy performance obligations under a contract. The majority of our contracts have performance obligations that are satisfied over time. In most cases, we view our performance obligations as promises to transfer a series of distinct services to our customers that are substantially the same and which have the same pattern of service. We recognize revenue over the performance period as a customer receives the benefits of our services.
Disaggregation of Revenue
In addition to our segment reporting, we disaggregate our revenues by service, contract type, and customer type.
Table 4.1: Revenue by Service Type
For the Three Months EndedFor the Six Months Ended
March 31, 2026March 31, 2025March 31, 2026March 31, 2025
(dollars in thousands)
Program Operations$644,892 49.4 %$690,772 50.7 %$1,321,299 49.8 %$1,418,739 51.3 %
Clinical Services530,808 40.6 %503,963 37.0 %1,054,527 39.8 %975,489 35.3 %
Employment & Other60,008 4.6 %78,989 5.8 %130,173 4.9 %192,607 7.0 %
Technology Solutions70,259 5.4 %88,062 6.5 %145,014 5.5 %177,626 6.4 %
Total revenue$1,305,967 $1,361,786 $2,651,013 $2,764,461 
Table 4.2: Revenue by Contract Type
For the Three Months EndedFor the Six Months Ended
March 31, 2026March 31, 2025March 31, 2026March 31, 2025
(in thousands)
Performance-based$733,098 56.1 %$714,406 52.5 %$1,453,759 54.8 %$1,432,177 51.8 %
Cost-plus343,924 26.3 %334,499 24.6 %730,312 27.5 %718,926 26.0 %
Fixed price165,608 12.7 %185,009 13.6 %334,127 12.6 %359,688 13.0 %
Time and materials63,337 4.8 %127,872 9.4 %132,815 5.0 %253,670 9.2 %
Total revenue$1,305,967 $1,361,786 $2,651,013 $2,764,461 
Table 4.3: Revenue by Customer Type
For the Three Months EndedFor the Six Months Ended
March 31, 2026March 31, 2025March 31, 2026March 31, 2025
(dollars in thousands)
New York state government agencies$147,360 11.3 %$155,949 11.5 %$297,481 11.2 %$317,644 11.5 %
Other U.S. state government agencies272,787 20.9 %287,184 21.1 %541,259 20.4 %578,251 20.9 %
Total U.S. state government agencies420,147 443,133 838,740 895,895 
U.S. federal government agencies734,888 56.3 %759,583 55.8 %1,502,691 56.7 %1,524,020 55.1 %
International government agencies134,847 10.3 %138,724 10.2 %275,859 10.4 %305,590 11.1 %
Other, including local municipalities and commercial customers16,085 1.2 %20,346 1.5 %33,723 1.3 %38,956 1.4 %
Total revenue$1,305,967 $1,361,786 $2,651,013 $2,764,461 

15

Table of Contents
Contract balances
Differences in timing between revenue recognition and cash collection result in contract assets and contract liabilities. We classify these assets as accounts receivable — billed and billable and unbilled receivables; the liabilities are classified as deferred revenue.
In many contracts, we bill our customers on a monthly basis shortly after the month end for work performed in that month, and such balances are considered collectible and are included within accounts receivable, net.
Exceptions to this pattern will arise for various reasons, including those listed below.
Under cost-plus contracts, we are typically required to estimate a contract's share of our general and administrative expenses. This share is based upon estimates of total costs, which may vary over time. We typically invoice our customers at an agreed provisional billing rate, which may differ from actual rates incurred. If our actual rates are higher than the provisional billing rates, an asset is recorded for this variance; if the provisional billing rates are higher than our actual rates, we record a liability.
Certain contracts include retainage balances, whereby revenue is earned, but some portion of cash payments are held back by the customer for a period of time, typically to allow the customer to confirm the objective criteria laid out by the contract have been met. This balance is classified as accounts receivable - unbilled, until restrictions on billing are lifted. As of March 31, 2026, and September 30, 2025, $21.6 million and $24.1 million, respectively, of our unbilled receivables related to amounts pursuant to contractual retainage provisions.
In certain contracts, we may receive funds from our customers prior to performing operations. These funds are typically referred to as "set-up costs" and reflect the need for us to make investments in infrastructure prior to providing a service. This investment in infrastructure is not a performance obligation that is distinct from the service that is subsequently provided and, as a result, revenue is not recognized based upon the establishment of this infrastructure, but rather over the course of the contractual relationship. The funds are initially recorded as deferred revenue and recognized over the term of the contract. Other contracts may not include set-up fees but will provide higher fees in earlier periods of the contract. The premium on these fees is deferred.
Some of our contracts, notably our employment services contracts in the Outside the U.S. Segment, include payments for specific milestones, such as job placement and job retention, and these outcome payments occur over several months. We are required to estimate these outcome fees ahead of their realization and recognize this estimated fee over the period of delivery.
During the three and six months ended March 31, 2026, we recognized revenue of $9.8 million and $43.2 million, respectively, included in our deferred revenue balances at September 30, 2025. During the three and six months ended March 31, 2025, we recognized revenue of $25.6 million and $73.2 million, respectively, included in our deferred revenue balances at September 30, 2024.
Contract estimates
We are required to use estimates in recognizing revenue from some of our contracts.
Certain performance-based contracts include variable consideration in the form of penalties and incentives, based upon our performance under the terms of the contract. The calculation of these penalties and incentives requires the evaluation of both objective and subjective criteria, which may require the use of estimates.
Within our employment services business in our Outside the U.S. Segment, some of our performance-based contract revenue is recognized based upon future milestones defined in each contract, which requires us to make estimates about the attainment of the milestones.
We estimate the total variable consideration we will receive using the expected value method. We recognize the revenue over the expected period of performance. At each reporting period, we update our estimates of the variable fees to represent the circumstances present at the end of the reporting period. We include variable consideration in our estimates to the extent it is probable that a subsequent change in the estimate will not result in a significant reversal of cumulative revenue when the uncertainty is resolved. We do not have a history of significant constraints on these contracts.
16

Table of Contents
Table 4.4: Effect of Changes in Contract Estimates
For the Three Months EndedFor the Six Months Ended
March 31, 2026March 31, 2025March 31, 2026March 31, 2025
(in thousands, except per share data)
Increase in revenue recognized due to changes in contract estimates$519 $3,804 $6,919 $10,573 
Increase in diluted earnings per share recognized due to changes in contract estimates$0.01 $0.05 $0.09 $0.13 
Remaining performance obligations
As of March 31, 2026, we had approximately $250 million of remaining performance obligations. We anticipate that we will recognize revenue on approximately 55% of this balance within the next 12 months. This balance excludes contracts with an original duration of twelve months or less, including contracts with a penalty-free termination for convenience clause, and any variable consideration that is allocated entirely to future performance obligations, including variable transaction fees or fees tied directly to costs incurred.

5. EARNINGS PER SHARE
Table 5: Weighted Average Number of Shares - Earnings Per Share
For the Three Months EndedFor the Six Months Ended
March 31, 2026March 31, 2025March 31, 2026March 31, 2025
(in thousands)
Basic weighted average shares outstanding54,242 56,892 54,547 58,330 
Dilutive effect of unvested RSUs and PSUs343 165 378 223 
Denominator for diluted earnings per share54,585 57,057 54,925 58,553 
The diluted earnings per share calculations for the three and six months ended March 31, 2026 exclude approximately 330,000 and 77,000 unvested anti-dilutive restricted stock units, respectively. The diluted earnings per share calculations for the three and six months ended March 31, 2025 exclude approximately 178,000 and 150,000 unvested anti-dilutive restricted stock units, respectively.
6. DIVESTITURES
U.S. Services Segment
In December 2025, we sold our child support business within the United States for approximately $14.0 million. This business had been reporting approximately $25.0 million of annual revenue. We recorded a gain on sale of $9.0 million.
Outside the U.S. Segment
In December 2024, we sold our businesses in Australia and Korea for a nominal sum. The sale agreement includes up to $5.0 million of contingent consideration based upon future performance. As of March 31, 2026, we have not recorded any potential contingent consideration. Our total divestiture-related charges of $39.5 million included approximately $21.3 million of previously unrealized foreign exchange losses, which we had recorded through other comprehensive income. We also provided an indemnification to the buyer that has been recorded at fair value in our consolidated balance sheets. No tax benefit is anticipated from this transaction.
17

Table of Contents
7. DEBT AND DERIVATIVES
Table 7.1: Details of Debt
March 31, 2026September 30, 2025
(in thousands)
Term Loan A (TLA)$830,625 $853,125 
Term Loan B (TLB)491,250 493,750 
Revolver225,000  
Total debt principal1,546,875 1,346,875 
Less: Unamortized debt-issuance costs and discounts(11,129)(12,602)
Total debt1,535,746 1,334,273 
Less: Current portion of long-term debt(63,930)(52,680)
Long-term debt$1,471,816 $1,281,593 
Our credit agreements require us to comply with a number of covenants, including leverage and interest coverage ratios. At March 31, 2026, we are in compliance with all covenants. We do not believe that the covenants represent a significant restriction on our ability to successfully operate the business or to pay dividends.
The following table sets forth future minimum principal payments due under our debt obligations as of March 31, 2026 for the remainder of fiscal year 2026 through fiscal year 2031:
Table 7.2: Details of Future Minimum Principal Payments Due
Amount Due
(in thousands)
April 1, 2026 through September 30, 2026$30,625 
Year ended September 30, 202772,500 
Year ended September 30, 202878,125 
Year ended September 30, 2029891,875 
Year ended September 30, 20305,000 
Years ended thereafter468,750 
Total payments$1,546,875 
Interest Rate Derivative Instruments
We utilize interest rate swaps that are designed to reduce our risk from changes in interest rates, which we have designated as cash flow hedges. The following table presents our interest rate swaps:
Table 7.3: Interest Rate Derivative Instruments
As of March 31, 2026
Debt Principal HedgedNotional AmountFixed Interest RateEffectiveExpiry
(in thousands)
Term Loan A$500,000 2.31 %PresentMay 2026
Term Loan B$75,000 3.72 %PresentSeptember 2026
Term Loan B$75,000 3.62 %PresentSeptember 2027
Term Loan A$150,000 3.14 %June 2026September 2027
Term Loan A$150,000 3.28 %June 2026September 2028
The balance of the debt pays interest based upon the Secured Overnight Financing Rate (SOFR). At March 31, 2026, our effective interest rate, including the original issuance costs and discount rate, was 5.0%.
At March 31, 2026, we recorded an asset of $3.2 million and a liability of $0.2 million to reflect the fair value of our interest rate swap agreements, compared to an asset of $5.5 million and a liability of $1.7 million at September 30, 2025. The assets and liabilities are recorded as "other assets" and "other liabilities," respectively, within our consolidated balance sheets. As these instruments are effective cash flow hedges, gains and losses based upon interest rate fluctuations are recorded within "accumulated other comprehensive loss" on our consolidated financial statements.
18

Table of Contents
8. FAIR VALUE MEASUREMENTS
We record the following assets and liabilities at fair value on a recurring basis.
We hold mutual fund assets within a Rabbi Trust to cover liabilities in our deferred compensation plan. These assets have prices quoted within active markets and, accordingly, are classified as level 1 within the fair value hierarchy.
We have interest rate swap agreements that are designed to manage our interest rate exposure. These agreements can be valued using observable data and, accordingly, are classified as level 2 within the fair value hierarchy.
In connection with the businesses sold in Australia and Korea, we indemnified the buyer related to certain potential losses, which are recorded at fair value, based on an assessment of probability-weighted outcomes. Accordingly, these inputs are not observable and are classified as level 3 within the fair value hierarchy. Changes in the fair value of the indemnification liability are recorded in the consolidated statements of operations.
The table below presents assets and liabilities measured and recorded at fair value in our consolidated balance sheets on a recurring basis and their corresponding level within the fair value hierarchy. No transfers between Level 1, Level 2, and Level 3 fair value measurements occurred for the six months ended March 31, 2026.
Table 8.1: Fair Value Measurements
As of March 31, 2026
Level 1Level 2Level 3Balance
(in thousands)
Assets:
Deferred compensation assets - Rabbi Trust$40,733 $ $ $40,733 
Interest rate swap - $675 million notional value
 3,209  3,209 
Total assets$40,733 $3,209 $ $43,942 
Liabilities:
Interest rate swap - $275 million notional value
$ $248 $ $248 
Indemnification liabilities  9,472 9,472 
Total liabilities$ $248 $9,472 $9,720 
The fair values of receivables, prepaid assets, other assets, accounts payable, accrued costs, and other current liabilities approximate the carrying values as a result of the short-term nature of these instruments. The carrying value of our debt is consistent with the fair value as the stated interest rates in the agreements are consistent with the current market rates used in notes with similar terms in the markets (Level 2 inputs).
Accumulated Other Comprehensive Loss
All amounts recorded in accumulated other comprehensive loss are related to our foreign currency translations and interest rate swaps, net of tax. The following table shows changes in accumulated other comprehensive loss. Amounts reclassified from other comprehensive income were recorded within our selling, general, and administrative expenses (for foreign currency translation adjustments) and within interest expense (for gains on derivatives).
Table 8.2: Details of Changes in Accumulated Other Comprehensive Loss by Category
Foreign currency translation adjustmentsNet unrealized gain on derivatives, net of taxTotal
(in thousands)
Balance as of September 30, 2025$(20,706)$2,839 $(17,867)
Other comprehensive income before reclassifications(2,531)2,313 (218)
Amounts reclassified from accumulated other comprehensive loss (2,970)(2,970)
Net current period other comprehensive income/(loss)(2,531)(657)(3,188)
Balance as of March 31, 2026$(23,237)$2,182 $(21,055)
19

Table of Contents
Indemnification Liability
The fair value of our indemnification liability is recorded at fair value as of the disposal date, based on an assessment of probability-weighted outcomes. This liability is reviewed on a quarterly basis. Changes in estimates are recorded to selling and general administrative expenses and foreign currency translation adjustments are recorded in other income/expenses on our Consolidated Statement of Operations.
Movement in our indemnification liability balance is as follows:
Table 8.3: Fair Value Measurement Using Significant Unobservable Inputs (Level 3)
Indemnification Liability
(in thousands)
Opening indemnification liability as of September 30, 2025$11,342 
Cash payments(1,599)
Foreign currency translation adjustments(271)
Closing indemnification liability as of March 31, 2026$9,472 

9. EQUITY
Stock Compensation
We grant restricted stock units (RSUs) and performance stock units (PSUs) to eligible participants under our 2021 Omnibus Incentive Plan, which was approved by our Board of Directors and stockholders. The RSUs granted to employees vest ratably over three to four years, with a small number which cliff vest after three years. The RSUs granted to directors cliff vest one year from the grant date. PSU vesting is subject to the achievement of certain performance and market conditions, and the number of PSUs earned could vary from 0% to 200% of the number of PSUs awarded. The PSUs will vest at the end of a three-year performance period if the performance conditions are met. We issue new shares to satisfy our obligations under these plans. The fair value of each RSU and PSU is calculated at the date of the grant.
During the six months ended March 31, 2026, we issued approximately 334,000 RSUs, which will vest ratably over one to four years, and approximately 146,000 PSUs, which will vest after three years if the performance conditions are met.
Stock Repurchase Programs
In September 2025, our Board of Directors authorized an increase to our existing stock purchase program that allows us to purchase, at management's discretion, up to $400 million of our common stock.
During the six months ended March 31, 2026, we purchased approximately 1.8 million common shares at a cost of $142.0 million, which includes an additional charge from the 1% excise tax on share purchases. During the six months ended March 31, 2025, we purchased approximately 4.1 million common shares at a cost of $309.5 million under a similar program.
At March 31, 2026, approximately $140.2 million remained available for future stock repurchases. Subsequent to March 31, 2026, we purchased an additional 0.6 million common shares at a cost of $39.9 million. In May 2026, our Board of Directors authorized an increase to our existing stock repurchase program, superseding earlier authorizations, which allows us to purchase, at management's discretion, up to an aggregate of $400 million of our common stock.
20

Table of Contents
10. OTHER ITEMS
Cash, Cash Equivalents, and Restricted Cash
Table 10.1: Details of Cash and Cash Equivalents and Restricted Cash
March 31, 2026September 30, 2025
(in thousands)
Cash and cash equivalents$157,452 $222,351 
Restricted cash87,245 38,108 
Cash, cash equivalents, and restricted cash$244,697 $260,459 
Restricted cash is recorded within "Prepaid expenses and other current assets" on the Consolidated Balance Sheets.
Table 10.2: Supplemental Disclosures of Cash Flow Information
For the Six Months Ended
March 31, 2026March 31, 2025
(in thousands)
Interest payments$41,395 $38,767 
Income tax payments$67,349 $70,397 
Accounts Receivable, Net
Table 10.3: Details of Accounts Receivable, Net
March 31, 2026September 30, 2025
(in thousands)
Billed and billable receivables$868,089 $720,495 
Unbilled receivables255,669 187,372 
Allowance for credit losses(8,798)(9,772)
Accounts receivable, net$1,114,960 $898,095 
We have a Receivables Purchase Agreement (RPA) with Wells Fargo Bank N.A., under which we may sell certain U.S.-originated accounts receivable balances up to a maximum amount of $350.0 million at any given time. In return for these sales, we receive a cash payment equal to the face value of the receivables less a financing charge.
We account for these transfers as sales. We have no retained interest in the transferred receivables other than administrative responsibilities, and Wells Fargo has no recourse for any credit risk. We estimate that the implicit servicing fees for an arrangement of this size and type would be immaterial.
For the six months ended March 31, 2026 and 2025, the value of accounts receivables transferred to Wells Fargo and derecognized from our balance sheet was $682.2 million and $377.2 million, respectively. In exchange for these sales, we received cash of $678.9 million and $374.9 million for the same periods, respectively. The difference, representing a loss on sale from these transfers, is included within our selling, general, and administrative expenses. We have recorded these transactions within our operating cash flows.

21

Table of Contents
11. COMMITMENTS AND CONTINGENCIES
Litigation
We are subject to audits, investigations, and reviews relating to compliance with the laws and regulations that govern our role as a contractor to agencies and departments of federal, state, local, and foreign governments. Adverse findings could lead to criminal, civil, or administrative proceedings, and we could be faced with penalties, fines, suspension, or debarment. Adverse findings could also have a material adverse effect on us because of our reliance on government contracts. We are subject to periodic audits by federal, state, local, and foreign governments for taxes. We are also involved in various claims, arbitrations, and lawsuits arising in the normal conduct of our business, which include but are not limited to bid protests, employment matters, contractual disputes, and charges before administrative agencies. Except for the matters described below for which we cannot predict the outcome, we do not believe the outcome of any existing matter would likely have a material adverse effect on our consolidated financial position, results of operations, or cash flows.
We evaluate developments in our litigation matters and establish or make adjustments to our accruals as appropriate. A liability is accrued if a loss is probable and the amount of such loss can be reasonably estimated. If the risk of loss is probable, but the amount cannot be reasonably estimated, or the risk of loss is only reasonably possible, a potential liability will be disclosed but not accrued, if material. Due to the inherent uncertainty in the outcome of litigation, our estimates and assessments may prove to be incomplete or inaccurate and could be impacted by unanticipated events and circumstances, adverse outcomes, or other future determinations.
MOVEit Cybersecurity Incident Litigation
As previously disclosed, on May 31, 2023, Progress Software Corporation, the developer of MOVEit, a file transfer application used by many organizations to transfer data, announced a critical zero-day vulnerability in the application that allowed unauthorized third parties to access its customers’ MOVEit environments. Maximus uses MOVEit for internal and external file sharing purposes, including to share data with government customers related to Maximus's services in support of certain government programs. Based on our review of the impacted files to date, we have provided notices to individuals whose personal information, including social security numbers, protected health information, and/or other personal information, may have been included in the impacted files.
On August 1, 2023, a purported class action was filed against Maximus Federal Services, Inc. (a wholly-owned subsidiary of Maximus, Inc.) in the U.S. District Court for the Eastern District of Virginia arising out of the MOVEit cybersecurity incident – Bishop v. Maximus Federal Services, Case No. 1:23-cv-01019 (U.S. Dist. Ct. E. D. VA). The plaintiff, who purports to represent a nationwide class of individuals, alleges, among other things, that our negligence resulted in the compromise of the plaintiff’s personally identifiable information and protected health information. The plaintiff seeks damages to be proved at trial. Since then, thirteen similar cases have been filed in federal courts across the country (inclusive of one case filed in state court and removed to federal court by us).
On October 4, 2023, the United States Judicial Panel on Multidistrict Litigation granted a Motion to Transfer creating a Multidistrict Litigation (MDL) in the District of Massachusetts for all cases related to the MOVEit cybersecurity incident. Each of the actions pending in federal courts are centralized in the MDL.
On December 12, 2024, the Court granted in part Defendants' omnibus motion to dismiss Plaintiffs’ claims pursuant to Rule 12(b)(1), challenging Plaintiffs’ standing to bring this suit, dismissing claims brought by four of the Plaintiffs in the MOVEit MDL. None of the dismissed claims were asserted against us.
The Court has also named us as a bellwether defendant in the MDL. We and the other bellwether defendants submitted motions to dismiss the pending actions pursuant to Rule 12(b)(6), which the Court granted in part and denied in part on July 31, 2025. Approximately half of the claims asserted against us remain, and we are proceeding to discovery regarding those claims.
Separately, there is currently an individual action pending against us in Florida state court. On September 6, 2023, an individual action related to the MOVEit incident was filed in state court in the Florida Circuit Court for the 7th Judicial Circuit, Volusia County: Taylor v. Maximus Federal Services, Case No. 2023-12349 (Fla. Cir. Ct., 7th Jud. Cir., Volusia Cnty.). The plaintiff alleges, among other things, that our negligence resulted in the compromise of the plaintiff’s personally identifiable information and protected health information. The plaintiff seeks damages to be proved at trial. On April 3, 2024, the Court stayed this action pending further developments in the MOVEit MDL. This case remains stayed.
While we are unable to predict the ultimate outcome of any of the remaining proceedings, we have accrued an amount within a range of possible outcomes expected to be incurred to resolve the matters.
22

Table of Contents
12. SUBSEQUENT EVENT
On April 6, 2026, our Board of Directors declared a quarterly cash dividend of $0.33 for each share of our common stock outstanding. The dividend is payable on June 1, 2026, to shareholders of record on May 15, 2026. Based upon the number of shares outstanding, we anticipate a cash payment of approximately $17.5 million.
23

Table of Contents
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The following discussion is intended to help the reader understand our business, financial condition, results of operations, liquidity and capital resources. You should read this discussion in conjunction with "Risk Factors," "Special Note Regarding Forward-Looking Statements," and our financial statements and related notes included in our Annual Report on Form 10-K for fiscal year 2025 filed with the SEC on November 20, 2025 and elsewhere in this Quarterly Report on Form 10-Q, as applicable.
Business Overview
Maximus is a leading provider of tech-enabled services to government agencies. By moving people, technology, and government forward, Maximus helps improve the delivery of public services for more than 100 million American citizens, as well as citizens in the United Kingdom (U.K.), Canada, and the Middle East, amid complex technological, health, economic, and social challenges. As a trusted and accountable partner to primarily U.S. federal and state customers, we proudly design, develop, and deliver innovative and efficient programs that are designed to improve government’s effectiveness in serving its citizens.
We create value for our customers through our ability to translate public policy into operating models that achieve outcomes for governments at scale. Our work covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. These services benefit from an industry with increasing demand, constrained government budgets, and an increased focus on technology as governments prioritize modernization. We also demonstrate the ability to move quickly, ranging from digitally enabled contact center support services for natural disaster response to swift establishments of public health and safety initiatives.

24

Table of Contents
Financial Overview
A number of factors have affected our results for the second quarter of fiscal year 2026. More detail on these changes is presented below within our "Results of Operations" section.

Results of Operations
The following table sets forth items from our consolidated statements of operations for the three and six months ended March 31, 2026, and March 31, 2025.
Table MD&A 1: Consolidated Results of Operations
For the Three Months EndedFor the Six Months Ended
March 31, 2026March 31, 2025March 31, 2026March 31, 2025
(dollars in thousands, except per share data)
Revenue$1,305,967 $1,361,786 $2,651,013 $2,764,461 
Cost of revenue963,703 1,022,965 1,990,079 2,124,083 
Gross profit342,264 338,821 660,934 640,378 
Gross profit percentage26.2 %24.9 %24.9 %23.2 %
Selling, general, and administrative expenses173,479 162,857 325,639 354,592 
Selling, general, and administrative expenses as a percentage of revenue13.3 %12.0 %12.3 %12.8 %
Amortization of intangible assets20,298 22,996 40,598 46,031 
Operating income148,487 152,968 294,697 239,755 
Operating margin11.4 %11.2 %11.1 %8.7 %
Interest expense22,111 21,469 42,927 38,991 
Other (income)/expense, net(158)(963)(1,031)(651)
Income before income taxes126,534 132,462 252,801 201,415 
Provision for income taxes28,471 35,893 60,795 63,650 
Effective tax rate22.5 %27.1 %24.0 %31.6 %
Net income$98,063 $96,569 $192,006 $137,765 
Earnings per share:
Basic$1.81 $1.70 $3.52 $2.36 
Diluted$1.80 $1.69 $3.50 $2.35 
Our business segments have different factors driving revenue fluctuations and profitability. The sections that follow cover these segments in greater detail. Our revenue reflects fees earned for services provided. Cost of revenue consists of direct costs related to labor and its associated overhead, subcontractor labor, outside vendors, rent, and other direct costs. The largest component of cost of revenue, approximately two-thirds, is labor, including subcontracted labor.
Table MD&A 2: Changes in Revenue, Cost of Revenue, and Gross Profit for the Three Months Ended March 31, 2026
RevenueCost of RevenueGross Profit
Dollars% ChangeDollars% ChangeDollars% Change
(dollars in thousands)
Three Months Ended March 31, 2025$1,361,786 $1,022,965 $338,821 
Organic effect(56,482)(4.1) %(60,572)(5.9) %4,090 1.2  %
Disposal of businesses(7,062)(0.5)%(5,700)(0.6)%(1,362)(0.4)%
Currency effect compared to the prior period7,725 0.6  %7,010 0.7  %715 0.2  %
Three Months Ended March 31, 2026$1,305,967 (4.1) %$963,703 (5.8) %$342,264 1.0  %



25

Table of Contents
Table MD&A 3: Changes in Revenue, Cost of Revenue, and Gross Profit for the Six Months Ended March 31, 2026
RevenueCost of RevenueGross Profit
Dollars% ChangeDollars% ChangeDollars% Change
(dollars in thousands)
Six Months Ended March 31, 2025$2,764,461 $2,124,083 $640,378 
Organic effect(97,806)(3.5)%(121,835)(5.7)%24,029 3.8 %
Disposal of businesses(27,624)(1.0)%(23,042)(1.1)%(4,582)(0.7)%
Currency effect compared to the prior period11,982 0.4 %10,873 0.5 %1,109 0.2 %
Six Months Ended March 31, 2026$2,651,013 (4.1)%$1,990,079 (6.3)%$660,934 3.2 %
Selling, general, and administrative expenses
Selling, general, and administrative (SG&A) expenses consist of indirect costs related to general management, marketing, and administration. It is primarily composed of labor costs. These costs may be incurred at a segment level, for dedicated resources that are not client-facing, or at a corporate level. We allocate corporate costs to segments on a consistent and rational basis. Fluctuations in our SG&A are primarily driven by changes in our administrative cost base, which are not directly driven by changes in our revenue. As part of our work for the U.S. federal government and many states, we allocate these costs using a methodology driven by the U.S. Federal Cost Accounting Standards.
Our SG&A expense for the six months ended March 31, 2026, includes $9.0 million of divestiture-related gain from the sale of our child support business within the United States, which we divested in December 2025. Our SG&A expense for the six months ended March 31, 2025, includes divestiture-related charges of $39.3 million from our sale of businesses in the Outside the U.S. Segment. These charges included accumulated foreign currency losses incurred over two decades of operations, as well as indemnifications provided to the buyer.
Amortization of intangible assets
Amortization of intangible assets has declined for the three and six months ended March 31, 2026, as compared to the same periods in fiscal year 2025, since the amortization of technology-based assets acquired in fiscal year 2021 was completed prior to fiscal year 2026.
Our balance sheet includes $380.4 million of intangible assets from a 2021 acquisition. These assets, comprised of customer relationships and a medical provider network, continue to support medical disability examinations (MDE) contracts with the U.S. Department of Veterans Affairs. These assets are being amortized over their remaining useful life of approximately seven years. In the event that our expectations change with respect to these acquired contracts, the value of these assets and the estimated remaining lives of these assets may need to be adjusted.
Interest Expense
During fiscal year 2025, we expanded our Term Loan A Credit Facility, which has resulted in an increase to our interest expense in the current year. We continue to mitigate a portion of our interest rate risk through hedging transactions on a portion of our outstanding debt.
Provision for Income Taxes
Our effective income tax rate for the three and six months ended March 31, 2026, was 22.5% and 24.0%, respectively, compared to 27.1% and 31.6% for the three and six months ended March 31, 2025, respectively. Our effective tax rate for the first half of fiscal year 2026 includes approximately $4.2 million of benefit from research and development tax credits identified and claimed in the period. Our tax rate in fiscal year 2025 was affected by the disposal of our businesses in Australia and Korea and other non recurring items. For fiscal year 2026, we expect an overall effective tax rate between 24% and 25%.
26

Table of Contents
U.S. Federal Services Segment
Our U.S. Federal Services Segment delivers solutions that help various U.S. federal government agencies better execute on their mission, including program operations and management, clinical services, and advanced technology solutions.
Table MD&A 4: U.S. Federal Services Segment - Financial Results
For the Three Months EndedFor the Six Months Ended
March 31, 2026March 31, 2025March 31, 2026March 31, 2025
(dollars in thousands)
Revenue$753,143 $777,927 $1,539,744 $1,558,582 
Cost of revenue527,698 575,869 1,099,364 1,183,209 
Gross profit225,445 202,058 440,380 375,373 
Selling, general, and administrative expenses92,741 83,076 177,943 157,291 
Operating income132,704 118,982 262,437 218,082 
Gross profit percentage29.9 %26.0 %28.6 %24.1 %
Operating margin percentage17.6 %15.3 %17.0 %14.0 %
Our revenue and cost of revenue for the three months ended March 31, 2026 and 2025 decreased 3.2% and 8.4%, respectively. Our revenue and cost of revenue for the six months ended March 31, 2026 and 2025 decreased 1.2% and 7.1%, respectively.
Our prior year revenue included the benefit of short-term disaster recovery work, which did not recur in fiscal year 2026. Absent this work, revenue would have grown approximately 1.5% for the three months ended March 31, 2026 compared to March 31, 2025, and 3.0% for the six months ended March 31, 2026 compared to six months ended March 31, 2025, principally driven by volume growth. Our margins have improved through a combination of efficiency savings through the use of technology and the absence of short-term disaster recovery work, which operated at lower margins than the core of our business.

Below is a reconciliation of revenue for the three and six months ended March 31, 2026 compared to the prior year period, including the impact of short‑term disaster recovery work and our organic revenue growth excluding this work.

Table MD&A 5: Change in Revenue, Excluding Natural Disaster Recovery Work
Three Months Ended
March 31, 2026
Six Months Ended
March 31, 2026
Dollars% ChangeDollars% Change
(dollars in thousands)
Revenue for 2025 fiscal period$777,927 $1,558,582 
Decline in short-term disaster recovery work(36,118)(4.6)%(64,927)(4.2)%
Organic revenue growth excluding short-term disaster recovery work11,334 1.5 %46,089 3.0 %
Revenue for 2026 fiscal period$753,143 (3.2)%$1,539,744 (1.2)%

We anticipate operating margin for the U.S. Federal Services Segment in fiscal year 2026 to be approximately 17.5%.
27

Table of Contents
U.S. Services Segment
Our U.S. Services Segment provides a variety of services, such as program operations, clinical services, employment services and advanced technology solutions and related professional services work for U.S. state and local government programs. These services support a variety of programs, including the programs under Medicaid and Children's Health Insurance Program (CHIP), the Affordable Care Act (ACA) marketplaces, and Temporary Assistance to Needy Families (TANF).
Table MD&A 6: U.S. Services Segment - Financial Results
For the Three Months EndedFor the Six Months Ended
March 31, 2026March 31, 2025March 31, 2026March 31, 2025
(dollars in thousands)
Revenue$415,754 $442,350 $831,002 $894,600 
Cost of revenue315,245 330,580 646,099 687,826 
Gross profit100,509 111,770 184,903 206,774 
Selling, general, and administrative expenses61,919 57,963 117,027 112,121 
Operating income38,590 53,807 67,876 94,653 
Gross profit percentage24.2 %25.3 %22.3 %23.1 %
Operating margin percentage9.3 %12.2 %8.2 %10.6 %
Our revenue and cost of revenue for the three months ended March 31, 2026 and 2025, decreased 6.0% and 4.6%, respectively. For the six months ended March 31, 2026 and 2025, our revenue and cost of revenue decreased 7.1% and 6.1%, respectively.
Table MD&A 7: U.S. Services Segment - Changes in Revenue, Cost of Revenue, and Gross Profit for the Three Months Ended March 31, 2026
RevenueCost of RevenueGross Profit
Amount% ChangeAmount% ChangeAmount% Change
(dollars in thousands)
Three Months Ended March 31, 2025$442,350 $330,580 $111,770 
Organic effect(19,534)(4.4)%(9,635)(2.9)%(9,899)(8.9)%
Disposal of businesses(7,062)(1.6)%(5,700)(1.7)%(1,362)(1.2)%
Three Months Ended March 31, 2026$415,754 (6.0)%$315,245 (4.6)%$100,509 (10.1)%
Table MD&A 8: U.S. Services Segment - Changes in Revenue, Cost of Revenue, and Gross Profit for the Six Months Ended March 31, 2026
RevenueCost of RevenueGross Profit
Amount% ChangeAmount% ChangeAmount% Change
(dollars in thousands)
Six Months Ended March 31, 2025$894,600 $687,826 $206,774 
Organic effect(55,350)(6.2)%(35,105)(5.1)%(20,245)(9.8)%
Disposal of businesses(8,248)(0.9)%(6,622)(1.0)%(1,626)(0.8)%
Six Months Ended March 31, 2026$831,002 (7.1)%$646,099 (6.1)%$184,903 (10.6)%
Our U.S. Services Segment continues to experience lower volumes and demand across a broad range of contracts compared to prior years. We believe the contracts and relationships held by this segment provide it with strong opportunities to assist state customers who will require higher engagement across their federally-funded social programs. Accordingly, we anticipate that we will return to organic growth towards the end of the current fiscal year.
During the second quarter of the year, we recorded an impairment charge of $6.9 million related to a capitalized software asset following a client decision which resulted in its carrying value no longer being recoverable. We anticipate operating margins for the U.S. Services Segment in fiscal year 2026 to be approximately 10%.
28

Table of Contents
Outside the U.S. Segment
Our Outside the U.S. Segment provides business process services and other solutions for international governments. These services include health and disability assessments, program administration for employment services, wellbeing solutions and other job seeker-related services, digitally-enabled customer services, and advanced technologies for modernization. We support programs and deliver services in the U.K., including the Functional Assessment Services (FAS) contract and the Restart employment program. We also provide services in Canada and the Middle East.
Table MD&A 9: Outside the U.S. Segment - Financial Results
For the Three Months EndedFor the Six Months Ended
March 31, 2026March 31, 2025March 31, 2026March 31, 2025
(dollars in thousands)
Revenue$137,070 $141,509 $280,267 $311,279 
Cost of revenue120,760 116,516 244,616 253,048 
Gross profit16,310 24,993 35,651 58,231 
Selling, general, and administrative expenses19,395 20,197 40,116 45,315 
Operating (loss)/income(3,085)4,796 (4,465)12,916 
Gross profit percentage11.9 %17.7 %12.7 %18.7 %
Operating margin percentage(2.3) %3.4 %(1.6) %4.1 %
Table MD&A 10: Outside the U.S. Segment - Changes in Revenue, Cost of Revenue, and Gross Profit for the Three Months Ended March 31, 2026
RevenueCost of RevenueGross Profit
Amount% ChangeAmount% ChangeAmount% Change
(dollars in thousands)
Three Months Ended March 31, 2025$141,509 $116,516 $24,993 
Organic effect(12,164)(8.6) %(2,766)(2.4) %(9,398)(37.6) %
Currency effect compared to the prior period7,725 5.5 %7,010 6.0 %715 2.9 %
Three Months Ended March 31, 2026$137,070 (3.1) %$120,760 3.6  %$16,310 (34.7) %
Table MD&A 11: Outside the U.S. Segment - Changes in Revenue, Cost of Revenue, and Gross Profit for the Six Months Ended March 31, 2026
RevenueCost of RevenueGross Profit
Amount% ChangeAmount% ChangeAmount% Change
(dollars in thousands)
Six Months Ended March 31, 2025$311,279 $253,048 $58,231 
Organic effect(23,618)(7.6)%(2,885)(1.1)%(20,733)(35.6)%
Disposal of businesses(19,376)(6.2)%(16,420)(6.5)%(2,956)(5.1)%
Currency effect compared to the prior period$11,982 3.8 %$10,873 4.3 %1,109 1.9 %
Six Months Ended March 31, 2026$280,267 (10.0)%$244,616 (3.3)%$35,651 (38.8)%
The organic decline in this segment relates to lower volumes on a number of our contracts.
The divestiture of our businesses in Australia and Korea occurred in December 2024.
The effects of the organic decline and the divestiture were partially offset by the strengthening of the British Pound against the U.S. Dollar.
Following the divestitures in both fiscal years 2024 and 2025, we have taken the opportunity to expand our business development initiatives. We are tracking a number of opportunities, with the aim of driving growth and margin improvement in this segment. For fiscal year 2026, we anticipate a breakeven operating margin.
29

Table of Contents
Liquidity and Capital Resources
Our primary sources of liquidity are cash on hand, cash from operations, our $750 million revolving credit facility, and our $350 million Receivables Purchase Agreement (RPA). As of March 31, 2026, we had $157.5 million in cash and cash equivalents. We believe that our current cash position, access to our debt facilities, and cash flow generated from operations should be sufficient for our operating requirements and should enable us to fund required long-term debt repayments, dividends, and any share repurchases we might choose to make. See "Note 7. Debt and Derivatives" to the Consolidated Financial Statements for a more detailed discussion of our debt financing arrangements.
We have included the following table showing our debt balances as of March 31, 2026, and their effective interest rates.
Table MD&A 12: Debt Balances and Interest Rates as of March 31, 2026
March 31, 2026
Carrying valueEffective cash interest rateInterest rate basis
(dollars in thousands)
Term Loan A - Hedged through May 2026$500,000 3.68 %Fixed rate of 2.31% plus margin. (1)
Term Loan A - Unhedged330,625 5.04 %Term SOFR reset monthly plus margin. (1)
Term Loan B - Hedged through September 202675,000 5.72 %Fixed Rate of 3.72% plus 2% margin.
Term Loan B - Hedged through September 202775,000 5.62 %Fixed Rate of 3.62% plus 2% margin.
Term Loan B - Unhedged341,250 5.67 %Term SOFR reset monthly plus 2% margin.
Revolver225,000 5.05 %Term SOFR reset monthly plus margin. (1)
Debt Principal$1,546,875 
(1) The applicable margin for Term Loan A ranges from 1% to 2%, depending on our leverage ratio as determined based on our most recently filed financial statements. As of March 31, 2026, the applicable margin was 1.375%.
Our effective interest rate reflects the drivers of our cash interest payments as of March 31, 2026, which can change based upon the reset of the rates. Including the amortization of the upfront payments, our effective interest rate as of March 31, 2026, was 5.0%.
The table below summarizes our change in cash, cash equivalents, and restricted cash.
Table MD&A 13: Net Change in Cash and Cash Equivalents and Restricted Cash
For the Six Months Ended
March 31, 2026March 31, 2025
(in thousands)
Operating activities:
Net cash used in operating activities$(54,876)$(37,282)
Net cash used in investing activities(3,877)(41,627)
Net cash provided by financing activities43,623 677 
Effect of foreign exchange rates on cash and cash equivalents and restricted cash(632)(1,593)
Net change in cash and cash equivalents and restricted cash$(15,762)$(79,825)
Net Cash Used in Operating Activities
We reported net cash used in operations of $54.9 million for the first six months of fiscal year 2026, compared to $37.3 million for the first six months of fiscal year 2025. We continue to experience administrative delays on payments from one of our large contracts with the U.S. federal government. We anticipate that our cash flows will improve in the second half of fiscal year 2026.
These short-term delays in collections are reflected in Days Sales Outstanding ("DSO") at March 31, 2026, which were 78 days, compared with 62 days at September 30, 2025. Excluding the effects of the RPA, DSO would have been 102 days and 73 days, respectively.


30

Table of Contents
Net Cash Used in Investing Activities
We reported net cash used in investing activities of $3.9 million for the first six months of fiscal year 2026, compared to net cash used in investing activities of $41.6 million for the first six months of fiscal year 2025.
In fiscal year 2025, we made significant investments in our capital base, most notably in updating technology on our Federal MDE contracts. Much of this update was completed in the third quarter of that year.
Our cash flows in fiscal year 2026 include the cash received from the sale of our child support business within the United States. The final purchase price will be calculated based upon a working capital calculation, which should be concluded during the third fiscal quarter of this year.
Net Cash Provided by Financing Activities
We reported net cash provided by financing activities of $43.6 million for the first six months of fiscal year 2026, compared to $0.7 million for the first six months of fiscal year 2025.
We have utilized our credit facilities in both years to cover the short-term delays in collections noted above. In addition, we have utilized $155.0 million and $306.4 million, in fiscal years 2026 and 2025, respectively, to purchase our common shares. We have certain contracts where we hold cash on behalf of our customers. We show these funds as restricted cash and include their movement within financing cash flows. During the current fiscal year, the customer under a single large contract has increased their volume of work with us, resulting in significant growth in this balance. The restricted cash asset is offset by a current liability.
Credit Facilities
Our principal debt agreement is with JPMorgan Chase Bank N.A. (the "Credit Agreement"). At March 31, 2026, we owed $1.55 billion under the Credit Agreement, with access to approximately $525.0 million through a revolving credit facility. Mandatory repayments are required under this agreement through May 2031, when the agreement ends, and must be renegotiated or the funds repaid.
The Credit Agreement contains a number of covenants. Failure to meet these requirements would result in a need to renegotiate the agreement, seek a waiver, or a requirement to repay our outstanding debt in full. There are two financial covenants, both defined in the Credit Agreement:
Our Consolidated Net Total Leverage Ratio means, for any twelve-month period, the ratio of our Funded Debt (as defined by the Credit Agreement), offset by up to $150 million of unrestricted cash (Consolidated Net Total Leverage), against our Consolidated EBITDA (as defined by the Credit Agreement). To comply with our Credit Agreement, this ratio cannot exceed 4.00:1.00 at the end of each quarter, with a step up to 4.50:1.00 under certain circumstances. This ratio also determines both our interest rate and the charge we pay on the unused component of our revolving credit facility, with the charge increasing as the Consolidated Net Total Leverage Ratio increases.
Our Consolidated Net Interest Coverage Ratio means, for any twelve-month period, the ratio of our Consolidated EBITDA against our Consolidated Net Interest Expense, as defined by the Credit Agreement. To comply with our Credit Agreement, this ratio cannot be less than 3.00:1.00 at the end of each quarter.
Consolidated EBITDA also drives certain permissions within the Credit Agreement, such as the level of investment we are entitled to make without seeking additional approval from our lenders.
Our Credit Agreement defines Consolidated EBITDA, as well as other components of the calculations above. The definition of Consolidated EBITDA requires us to include adjustments not typically included within EBITDA, including unusual, non-recurring expenses, certain non-cash adjustments, the pro forma effects of acquisitions and disposals, and estimated synergies from acquisitions. As a result, Consolidated EBITDA as defined by the Credit Agreement may not be comparable to EBITDA or related or similarly titled measures presented by other companies.
We have summarized below the components of our two financial ratio calculations, including the components of Consolidated EBITDA as defined by the Credit Agreement which are included within our financial statements. At March 31, 2026, we were in compliance with all applicable covenants of our Credit Agreement. We do not believe that these covenants represent a significant restriction on our ability to operate our business or to pay our dividends.
31

Table of Contents
Table MD&A 14: Reconciliation of Net Income to Consolidated EBITDA as defined by our Credit Agreement
For the Three Months EndedFor the Trailing Twelve
Months Ended
March 31, 2026March 31, 2026
(in thousands)
Net income$98,063 $373,275 
Adjustments:
Interest expense22,111 88,016 
Other (income)/expense, net(158)(1,019)
Provision for income taxes28,471 122,960 
Amortization of intangibles20,298 86,614 
Stock compensation expense9,899 38,526 
Capitalized software impairment charges6,914 6,914 
Divestiture-related (gains)/charges, net— (8,779)
Depreciation and amortization of property, equipment, and capitalized software12,328 48,991 
Pro forma and other adjustments permitted by our Credit Agreement4,573 40,877 
Consolidated EBITDA (as defined by our Credit Agreement)$202,499 $796,375 
Table MD&A 15: Consolidated Net Total Leverage Ratio
For the Trailing Twelve
Months Ended
March 31, 2026
(in thousands, except ratio data)
Funded Debt (as defined by our Credit Agreement)$1,546,875 
Cash and cash equivalents up to $150 million150,000 
Consolidated Net Total Leverage (as defined by our Credit Agreement)$1,396,875 
Consolidated Net Total Leverage Ratio (as defined by our Credit Agreement)1.75 
Table MD&A 16: Consolidated Net Interest Coverage Ratio
For the Trailing Twelve
Months Ended
March 31, 2026
(in thousands, except ratio data)
Consolidated EBITDA (as defined by our Credit Agreement)$796,375 
Interest expense88,016 
Components of other income/expense, net allowed in ratio calculation2,091 
Consolidated Net Interest Expense (as defined by our Credit Agreement)$90,107 
Consolidated Net Interest Coverage Ratio (as defined by our Credit Agreement)8.84 
32

Table of Contents
Cash in Foreign Locations
We have no requirement to remit funds from our foreign locations to the United States. We will continue to explore opportunities to remit additional funds, taking into consideration the working capital requirements and relevant tax rules in each jurisdiction. When we are unable to remit funds back without incurring a penalty, we will consider these funds indefinitely reinvested until such time as these restrictions are changed. As a result, we do not record U.S. deferred income taxes on any funds held in foreign jurisdictions. We have not attempted to calculate our potential liability from any transfer of these funds, as any such transaction might include tax planning strategies that we have not fully explored. Accordingly, it is not possible to estimate the potential tax obligations if we were to remit all of our funds from foreign locations to the United States.
Free Cash Flow (Non-GAAP)
Table MD&A 17: Free Cash Flow (Non-GAAP)
For the Six Months Ended
March 31, 2026March 31, 2025
(in thousands)
Net cash used in operating activities$(54,876)(37,282)
Purchases of property and equipment and capitalized software(16,772)(40,198)
Free cash flow (Non-GAAP)$(71,648)$(77,480)
Critical Accounting Policies and Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. requires us to make estimates, judgments, and assumptions that affect the amounts reported. Actual results could differ from those estimates. Our Annual Report on Form 10-K, filed with the SEC on November 20, 2025, includes a summary of critical accounting policies we believe are the most important to aid in understanding our financial results. There have been no changes to those critical accounting policies that have had a material impact on our reported amounts of assets, liabilities, revenues, or expenses during the six months ended March 31, 2026.

Non-GAAP and Other Measures
We utilize non-GAAP measures where we believe it will assist users of our financial statements in understanding our business. The presentation of these measures is meant to complement, but not replace, other financial measures in this document. The presentation of non-GAAP numbers is not meant to be considered in isolation, nor as an alternative to revenue growth, net cash used in operating activities, operating income, net income, or earnings per share as measures of performance or liquidity. These non-GAAP measures, as determined and presented by us, may not be comparable to related or similarly titled measures presented by other companies.
For the three months ended March 31, 2026, 10% of our revenue was generated outside the U.S. We believe that users of our financial statements want to understand the performance of our foreign operations using a methodology that excludes the effect of year-over-year exchange rate fluctuations. To calculate year-over-year currency movement, we determine the current fiscal year's results for all foreign businesses using the exchange rates in the prior fiscal year.
From time to time, we enter into acquisitions and divestitures. We believe users of our financial statements want to evaluate the performance of our operations, excluding changes that have arisen due to businesses acquired or disposed of. We identify acquired revenue and cost of revenue by showing these results for periods for which no comparative results exist within our financial statements. We identify revenue and cost of revenue that has been disposed of in a similar manner. This information is supplemented by our calculations of organic growth. To calculate organic growth, we compare current fiscal year results, excluding transactions from acquisitions or disposals, to our prior fiscal year results.
Our previous acquisitions have resulted in significant intangible assets, which are amortized over their estimated useful lives. We believe users of our financial statements want to understand the performance of the business by using a methodology that excludes the amortization of our intangible assets. For the six months ended March 31, 2026 and 2025, we also incurred gains and losses on sales of businesses. We believe that providing supplemental measures that exclude the impact of the items detailed below is useful to investors in evaluating our core operations and results in relation to past periods. Accordingly, we have calculated our net income and diluted earnings per share, excluding the effects of the amortization of intangible assets and divestiture-related gains and charges. Although these measures exclude the amortization of intangible assets acquired as part of our acquisitions, they do include the post-acquisition revenue from
33

Table of Contents
the acquired businesses. In addition, Adjusted EBITDA, as calculated by us, is also a useful measure of performance that focuses on the cash generating capacity of the business as it excludes the non-cash expenses of depreciation and amortization of property, equipment, and capitalized software, amortization of intangible assets, capitalized software impairment charges, and divestiture-related activity. We believe that these non-GAAP measures assist investors in making comparisons between the operating performance of companies with different capital structures by excluding interest expense and therefore, the impacts of financing costs. Although Adjusted EBITDA excludes the amortization of intangible assets acquired as part of our acquisitions, it does include the post-acquisition revenue from the acquired businesses. As disclosed above, Adjusted EBITDA is calculated in a different manner from Consolidated EBITDA, as defined by our Credit Agreement.
We have included a table showing our reconciliation of these income measures to their corresponding GAAP measures.
Table MD&A 18: Non-GAAP Adjusted Results - Adjusted EBITDA, Adjusted Net Income, and Adjusted Diluted Earnings per Share
For the Three Months EndedFor the Six Months Ended
March 31, 2026March 31, 2025March 31, 2026March 31, 2025
(dollars in thousands, except per share data)
Net income$98,063 $96,569 $192,006 $137,765 
Provision for income taxes28,471 35,893 60,795 63,650 
Interest expense22,111 21,469 42,927 38,991 
Other (income)/expense, net(158)(963)(1,031)(651)
Amortization of intangible assets20,298 22,996 40,598 46,031 
Divestiture-related charges/(gains)— 1,002 (8,985)39,343 
Depreciation and amortization of property, equipment, and capitalized software12,328 9,440 25,217 17,895 
Capitalized software impairment charges6,914 — 6,914 — 
Adjusted EBITDA (Non-GAAP)$188,027 $186,406 $358,441 $343,024 
Net income margin (GAAP)*7.5 %7.1 %7.2 %5.0 %
Adjusted EBITDA margin (Non-GAAP)*14.4 %13.7 %13.5 %12.4 %
* Margins are calculated as a percentage of revenue
Net income$98,063 $96,569 $192,006 $137,765 
Add back: Amortization of intangible assets, net of tax14,960 16,948 29,921 33,925 
Add back: Divestiture-related charges/(gains), net of tax— 1,002 (6,622)39,343 
Adjusted net income excluding amortization of intangible assets and divestiture-related adjustments (Non-GAAP)$113,023 $114,519 $215,305 $211,033 
Diluted earnings per share$1.80 $1.69 $3.50 $2.35 
Add back: Effect of amortization of intangible assets on diluted earnings per share0.27 0.30 0.54 0.58 
Add back: Effect of divestiture-related charges/(gains) on diluted earnings per share— 0.02 (0.12)0.67 
Adjusted diluted earnings per share excluding amortization of intangible assets and divestiture-related adjustments (Non-GAAP)$2.07 $2.01 $3.92 $3.60 
34

Table of Contents
In order to sustain our cash flows from operations, we regularly refresh our fixed assets and technology. We believe that users of our financial statements want to understand the cash flows that directly correspond with our operations and the investments we must make in those operations using a methodology that combines operating cash flows and capital expenditures. We provide free cash flow to complement our statement of cash flows. Free cash flow shows the effects of our operations and replacement capital expenditures and excludes the cash flow effects of acquisitions, purchases of our common stock, dividend payments, and other financing transactions. We have provided a reconciliation of cash flows from operations to free cash flow in "Liquidity and Capital Resources."
To sustain our operations, our principal source of financing comes from receiving payments from our customers. We believe that users of our financial statements want to evaluate our efficiency in converting revenue into cash receipts. Accordingly, we provide DSO, which we calculate by dividing billed and unbilled receivable balances at the end of each quarter by revenue per day for the quarter. Revenue per day for a quarter is determined by dividing total revenue by 91 days.
35

Table of Contents
Item 3. Quantitative and Qualitative Disclosures About Market Risk
In the normal course of business, we are exposed to financial risks such as changes in interest rates, foreign currency exchange rates, and counterparty risk. We use derivative instruments to manage selected interest rate exposures. The Company's market rate risk disclosures set forth in Part II, Item 7A, "Quantitative and Qualitative Disclosures About Market Risk" on our Annual Report on Form 10-K, filed with the SEC on November 20, 2025, have not changed materially during the six month period ended March 31, 2026.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our principal executive officer and principal financial officer, has evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act")) as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on this evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures are effective and designed to ensure that the information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified by the SEC's rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.
Changes in Internal Control Over Financial Reporting
There was no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) identified in connection with the evaluation of our internal control that occurred during our last fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

36

Table of Contents
PART II - Other Information
Item 1. Legal Proceedings
Refer to our disclosures included in "Note 11. Commitments and Contingencies" included in Part 1, Item 1 of this Quarterly Report on Form 10-Q.
Item 1A. Risk Factors
There were no material changes during the six months ended March 31, 2026 to the risk factors previously disclosed in our Annual Report on Form 10-K, filed with the SEC on November 20, 2025.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
(a)None.
(b)None.
(c)The following table sets forth the information required regarding purchases of common stock that we made during the three months ended March 31, 2026.
Common Stock Repurchase Activity During the Three Months Ended March 31, 2026
PeriodTotal Number of Shares PurchasedAverage Price Paid Per Share
Total Number of Shares Purchased as Part of the Publicly Announced Plans or Programs (1)
Maximum Dollar Value that May Yet Be Purchased Under the Plans or Programs (in thousands)
January 1, 2026 - January 31, 2026— $— — $250,034 
February 1, 2026 - February 28, 2026923,700 75.65 923,700 $180,158 
March 1, 2026 - March 31, 2026521,600 76.60 521,600 $140,201 
Total1,445,300 $75.99 1,445,300 
1.In September 2025, the Board of Directors authorized an increase to our existing stock purchase program whereby we may purchase, at management's discretion, up to $400 million of our common stock.
Item 3. Defaults Upon Senior Securities
(a)None.
(b)None.
Item 4. Mine Safety Disclosures
Not applicable.
Item 5. Other Information
(a)None.
(b)None.
(c)During the three months ended March 31, 2026, no director or officer of the Company adopted, modified, or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.
37

Table of Contents
Item 6. Exhibits
Exhibit
No.
Description of Exhibit
31.1
v
Certification of Chief Executive Officer pursuant to Section 302 of Sarbanes-Oxley Act of 2002.
31.2
v
Certification of Chief Financial Officer pursuant to Section 302 of Sarbanes-Oxley Act of 2002.
32.1
Φ
Certification of Chief Executive Officer pursuant to Section 906 of Sarbanes-Oxley Act of 2002.
32.2
Φ
Certification of Chief Financial Officer pursuant to Section 906 of Sarbanes-Oxley Act of 2002.
101.INSvInline XBRL Instance Document.
101.SCHvInline XBRL Taxonomy Extension Schema Document.
101.CALvInline XBRL Taxonomy Calculation Linkbase Document.
101.DEFvInline XBRL Taxonomy Definition Linkbase Document.
101.LABvInline XBRL Taxonomy Label Linkbase Document.
101.PREvInline XBRL Taxonomy Presentation Linkbase Document.
104vCover Page Interactive Data File (formatted as Inline XBRL tags and contained in Exhibit 101).
vFiled herewith.
ΦFurnished herewith.
38

Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Maximus, Inc.
/s/ Bruce L. CaswellMay 7, 2026
By:Bruce L. Caswell
 President and Chief Executive Officer
 (Principal Executive Officer)
/s/ David W. MutrynMay 7, 2026
By:David W. Mutryn
Chief Financial Officer
(Principal Financial Officer)
39

FAQ

How did Maximus (MMS) perform financially in Q2 2026?

Maximus delivered higher profit on slightly lower revenue in Q2 2026. Revenue was $1.31 billion versus $1.36 billion a year earlier, while net income increased to $98.1 million and diluted EPS rose to $1.80, supported by stronger gross and operating margins.

What were Maximus (MMS) results for the first half of fiscal 2026?

For the first six months of fiscal 2026, Maximus reported revenue of $2.65 billion and net income of $192.0 million. This compares with $2.76 billion revenue and $137.8 million net income a year earlier, reflecting improved profitability despite a 4.1% revenue decline.

How are Maximus’s business segments performing in 2026?

In the first half of 2026, U.S. Federal Services generated revenue of $1.54 billion and a 17.0% operating margin. U.S. Services revenue fell to $831.0 million with an 8.2% operating margin, while Outside the U.S. revenue declined to $280.3 million and posted an operating loss.

What is Maximus’s leverage and debt position as of March 31, 2026?

As of March 31, 2026, Maximus had total debt principal of $1.55 billion, mainly under Term Loan A, Term Loan B, and its revolver. The company reported a Consolidated Net Total Leverage Ratio of 1.75x and an effective interest rate of about 5.0% on its borrowings.

How much cash flow did Maximus (MMS) generate in the first half of 2026?

Maximus reported negative operating cash flow of $54.9 million for the first six months of 2026. Management attributes this mainly to administrative delays in payments on a large U.S. federal contract, which also increased days sales outstanding compared with the prior fiscal year-end.

What capital returns did Maximus provide to shareholders in early 2026?

During the first half of fiscal 2026, Maximus repurchased about 1.8 million shares for $142.0 million under its stock buyback program. The board also declared a quarterly cash dividend of $0.33 per share, with an expected total payment of roughly $17.5 million.

What is the status of Maximus’s MOVEit cybersecurity incident litigation?

Maximus continues to face consolidated U.S. federal multidistrict litigation and a stayed Florida state case related to the MOVEit cybersecurity incident. Some claims in the multidistrict matter were dismissed, others proceed in discovery, and the company has recorded an accrual within a range of possible resolution outcomes.